GI-bleeding

K11_GIBLEEDING

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K92.0, K92.1, K92.2 Hospital discharge: ICD-9 — 578 Cause of death: ICD-10 — K92.0, K92.1, K92.2 Cause of death: ICD-9 — 578 2 out of 7 registries used, show all original rules.	15057
4. Check minimum number of events None	15057
5. Include endpoints None	15057
6. Filter based on genotype QC (FinnGen only)	15057

Control definitions (FinnGen only)

Control exclude: K11_OTHDIG

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_GIBLEEDING
CONTROL_EXCLUDE	K11_OTHDIG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K92[0-2]
HD_ICD_9	578
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K92[0-2]
COD_ICD_9	578
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to GI-bleeding based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	15057	5904	9153
Unadjusted period prevalence (%)	3.24	2.01	4.04
Median age at first event (years)	66.08	64.38	67.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13559: Matched controls
135557

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D64.9

ICD-10 Finland

Anaemia, unspecified

3.7

323.0

2649

8306

C03CA01

ATC

furosemide; systemic

2.1

323.0

5592

33401

K92.0

ICD-10 Finland

Haematemesis

828.7

323.0

3835

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

39.4

323.0

443

116

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

323.0

5112

28561

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

24.0

323.0

817

361

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

323.0

3173

14186

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

+∞

323.0

396

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

26.2

323.0

520

206

UJF92

NOMESCO Finland

Capsular endoscopy

11.4

323.0

687

629

K92.1

ICD-10 Finland

Melaena

259.6

323.0

7721

687

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.2

323.0

1505

3891

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

8.2

323.0

8478

22841

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

160.2

323.0

3492

293

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

8.7

323.0

1325

1661

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.8

323.0

1679

4833

A02BC02

ATC

pantoprazole; systemic

3.1

323.0

9963

64210

UJD02

NOMESCO Finland

Gastroscopy

4.7

323.0

1232

2810

UJF32

NOMESCO Finland

Coloscopy

4.0

323.0

5791

21220

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

6.2

323.0

1581

2813

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

309.5

3442

17200

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

301.6

2375

9820

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.3

285.6

1646

5519

WW500

NOMESCO Finland

Blood transfusion

4.8

281.3

1001

2194

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

18.9

281.2

441

240

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

269.4

6370

42999

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

266.0

2591

11975

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

10.3

263.0

538

540

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

256.9

1614

5728

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

15.2

248.5

424

288

5780A

ICD-9 Finland

Gastro-intestinal haemorrhage, Haematemesis

+∞

243.4

233

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

238.6

1822

7306

N02AX02

ATC

tramadol; systemic, rectal

1.8

238.1

5947

40295

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

7.2

237.2

604

870

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

231.4

2696

13499

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

228.8

2878

14911

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

49.9

228.7

279

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.1

226.2

1373

4735

5781B

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]

+∞

220.3

211

WX892

NOMESCO Finland

Monitored bed care

2.9

219.5

1459

5342

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

217.2

1668

6684

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.4

215.9

497

612

JN3AD

NOMESCO Finland

Abdominal CT examination

3.0

210.2

1366

4923

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

55.5

209.7

251

R53

ICD-10 Finland

Malaise and fatigue

2.0

206.2

3098

17202

A02BC01

ATC

omeprazole; systemic

1.9

205.4

4081

25177

A02BC05

ATC

esomeprazole; systemic

1.8

198.7

5176

34883

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

9.8

198.4

415

433

A02BC03

ATC

lansoprazole; oral

1.8

190.9

4066

25558

A06AD11

ATC

lactulose; oral

2.1

189.6

2636

14110

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

35.0

189.2

248

R11

ICD-10 Finland

Nausea and vomiting

2.8

188.7

1340

5093

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

187.0

4020

25310

N02BE01

ATC

paracetamol; systemic, rectal

1.9

186.6

11049

94885

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

185.4

1928

9044

C03DA01

ATC

spironolactone; oral

2.3

184.0

1944

9184

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

33.7

183.0

242

AA1AD

NOMESCO Finland

CT of head and brain

1.9

181.4

3592

21939

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.4

179.6

569

1086

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

179.4

1732

7817

ZX120

NOMESCO Finland

Intravenous

2.5

174.3

1515

6462

N02AA05

ATC

oxycodone; systemic

2.1

173.3

2392

12707

J01MA02

ATC

ciprofloxacin; systemic

1.7

173.0

5420

38146

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

172.6

1682

7617

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

171.2

2112

10688

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

168.4

1349

5492

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

167.5

2666

14963

C07AB07

ATC

bisoprolol; oral

1.6

166.7

6785

51207

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

166.1

2685

15156

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.8

165.2

435

655

B01AB05

ATC

enoxaparin; parenteral

1.8

163.9

4050

26427

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

162.7

1520

6723

N05CF01

ATC

zopiclone; oral

1.7

162.7

4549

30805

N06AX11

ATC

mirtazapine; oral

1.8

159.9

3967

25869

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

8.0

159.8

378

485

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

154.2

898

2978

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.9

153.3

452

790

WX002

NOMESCO Finland

Sedation and analgesia

1.9

152.5

2704

15725

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

152.3

3479

22038

P01AB01

ATC

metronidazole; oral, rectal

1.7

151.8

4518

30992

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

19.3

151.4

235

124

N05AH04

ATC

quetiapine; oral

2.1

151.0

2079

10963

P15

ICPC

Chronic alcohol abuse

4.9

151.0

522

1097

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

9.3

150.6

324

355

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

149.2

1033

3839

F10.24

ICD-10 Finland

Alcohol depence active use

7.6

148.9

363

488

J01DB01

ATC

cefalexin; oral

1.7

147.2

10114

86313

H02AB06

ATC

prednisolone; systemic

1.6

146.6

5989

44640

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

145.3

4192

28410

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

142.9

1426

6495

K22.1

ICD-10 Finland

Ulcer of oesophagus

5.2

141.8

463

913

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

138.9

3863

25830

R06.0

ICD-10 Finland

Dyspnoea

1.7

138.7

3397

21870

R50.9

ICD-10 Finland

Fever, unspecified

2.0

138.5

2002

10735

J01MA12

ATC

levofloxacin; systemic

1.8

137.9

2704

16206

B01AA03

ATC

warfarin; systemic

1.7

136.6

3499

22812

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.6

135.8

653

1868

N07BB01

ATC

disulfiram; oral

3.4

135.6

705

2145

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

131.0

2265

12964

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.1

129.1

371

627

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.1

127.8

529

1328

A07EC02

ATC

mesalazine; oral, rectal

2.9

124.4

812

2898

N05BA04

ATC

oxazepam; oral

1.7

123.8

3131

20233

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

14.1

122.9

215

155

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

121.6

1936

10725

N06AB04

ATC

citalopram; systemic

1.8

120.4

2647

16368

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.8

118.4

413

875

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

118.3

890

3465

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.2

117.8

669

2169

K92.9

ICD-10 Finland

Disease of digestive system, unspecified

38.2

117.8

151

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

116.5

1245

5830

A02BA02

ATC

ranitidine; systemic

1.7

113.6

2756

17516

JN4BD

NOMESCO Finland

Extensive body CT

2.0

113.5

1588

8348

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

112.3

605

1887

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.6

111.7

299

460

R18

ICD-10 Finland

Ascites

4.8

111.5

394

846

N03AX16

ATC

pregabalin; oral

1.7

110.0

2848

18426

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

108.7

1100

5009

C07AA05

ATC

propranolol; systemic

1.8

108.5

2089

12326

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

107.9

1946

11225

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

106.6

368

771

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

106.5

3357

22894

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

106.4

830

3296

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

105.7

4003

28582

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

105.7

1085

4975

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

105.6

2494

15678

M04AA01

ATC

allopurinol; systemic

1.8

105.6

2124

12699

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

105.5

472

1268

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

105.5

1914

11059

SPAT1263

SPAT

Sampling

1.5

105.1

5165

39172

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

105.0

7776

64399

R4110

NOMESCO Finland

Physiotherapy

1.6

104.9

3272

22238

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

104.3

726

2692

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.2

104.2

262

369

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

104.2

595

1936

N05BA01

ATC

diazepam; systemic, rectal

1.9

103.9

1779

10068

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

103.8

626

2114

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

102.6

772

3001

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

102.3

3441

23816

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

101.9

911

3895

A28

ICPC

Limited function/disability NOS

1.7

101.1

2299

14269

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

100.9

1367

7075

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

100.3

715

2691

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

6.9

99.9

260

385

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.2

98.9

201

199

TK800

NOMESCO Finland

Hemodialysis

4.0

98.1

415

1061

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

97.2

5260

40515

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

96.7

438

1189

A46

ICD-10 Finland

Erysipelas

1.8

96.4

1986

11933

SPAT1254

SPAT

Administration of medicine

1.7

95.2

2093

12828

J01FF01

ATC

clindamycin; systemic

1.6

95.1

3190

21987

K90.0

ICD-10 Finland

Coeliac disease

10.3

92.9

188

185

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

92.7

2195

13746

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

92.0

1580

8921

I50.0

ICD-10 Finland

Congestive heart failure

2.0

91.7

1356

7248

JAH00

NOMESCO Finland

Laparotomy

3.3

91.5

482

1477

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.0

90.3

260

441

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

89.4

1043

5057

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

89.3

2543

16757

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

89.3

3695

26705

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

89.3

2453

16007

R51.80

ICD-10 Finland

Headache

1.9

88.3

1543

8755

K70.4

ICD-10 Finland

Alcoholic hepatic failure

13.8

87.1

153

112

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.9

87.1

254

438

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

86.8

1930

11837

K55.8

ICD-10 Finland

Other vascular disorders of intestine

10.7

86.7

172

163

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

86.6

2168

13769

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

86.6

785

3373

C08CA01

ATC

amlodipine; oral

1.5

85.9

4741

36380

K20

ICD-10 Finland

Oesophagitis

4.4

85.6

322

737

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.2

85.4

278

546

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

85.3

1408

7825

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.8

85.2

298

633

A04

ICPC

Weakness/tiredness general

1.8

85.2

1686

9966

L04AX01

ATC

azathioprine; systemic

2.8

84.1

591

2201

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

83.9

2025

12716

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.8

83.7

575

2109

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

82.6

2901

20105

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

82.5

3793

27950

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.5

82.3

201

272

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.4

81.7

420

1263

L28

ICPC

Limited function/disability (L)

1.7

81.1

2131

13695

N06AX16

ATC

venlafaxine; oral

1.9

80.9

1322

7313

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

80.3

1782

10902

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

79.7

3635

26699

SPAT1301

SPAT

No procedures

1.5

79.1

3935

29430

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

79.0

1033

5245

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.4

78.8

216

344

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

78.8

896

4287

N05AA02

ATC

levomepromazine; systemic

2.6

78.8

608

2392

K51.5

ICD-10 Finland

Left sided colitis

3.5

78.7

389

1134

M79.6

ICD-10 Finland

Pain in limb

1.5

78.7

3906

29187

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

78.6

3496

25525

N05CD07

ATC

temazepam; oral

1.7

78.5

1865

11635

JN4AD

NOMESCO Finland

Body CT examination

2.0

78.1

1025

5212

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.7

77.8

187

247

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

77.6

694

2959

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

77.5

1408

8075

P16

ICPC

Acute alcohol abuse

4.7

77.3

272

582

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.8

77.2

344

921

B82

ICPC

Anaemia other/unspecified

3.2

77.0

424

1342

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

76.2

748

3342

M54.5

ICD-10 Finland

Low back pain

1.5

76.1

3463

25372

K29.7

ICD-10 Finland

Gastritis, unspecified

2.8

76.0

527

1947

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.8

75.5

332

879

B01AB10

ATC

tinzaparin; parenteral

2.1

75.5

886

4297

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.6

75.4

200

305

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

75.2

2730

19003

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

74.4

860

4142

A11CC03

ATC

alfacalcidol; systemic

3.3

74.3

397

1229

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

74.2

429

1406

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

73.7

2196

14551

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

73.6

854

4121

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.0

73.4

188

273

3AC01

NOMESCO Finland

5.6

73.4

223

405

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

73.3

446

1513

A10AE04

ATC

insulin glargine; parenteral

1.8

73.0

1276

7214

R42

ICD-10 Finland

Dizziness and giddiness

1.5

72.8

2728

19115

D15

ICPC

Melaena

11.4

72.7

139

123

S06.0

ICD-10 Finland

Concussion

1.8

72.7

1277

7234

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.8

71.6

212

373

UJF02

NOMESCO Finland

Peroral enteroscopy

8.3

71.3

162

196

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

10.2

71.2

144

142

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.9

71.0

243

505

SPAT1262

SPAT

Handing over of treatment supplies

1.6

70.9

2334

15843

R04.0

ICD-10 Finland

Epistaxis

2.0

70.8

1048

5580

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

70.4

3006

21658

J01DA01

ATC

[U] cefalexin; systemic

1.4

69.8

7406

63182

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

30.2

69.0

JFB00

NOMESCO Finland

Partial resection of small intestine

4.0

68.8

291

745

B01AC04

ATC

clopidogrel; oral

1.6

68.2

2274

15463

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

68.1

981

5166

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.2

67.9

372

1173

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

67.8

1999

13180

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

67.8

3912

29924

WX882

NOMESCO Finland

High dependency care

2.9

67.7

445

1587

D16

ICPC

Rectal bleeding

3.6

67.5

322

913

E87.6

ICD-10 Finland

Hypokalaemia

2.8

66.9

456

1665

N06AB10

ATC

escitalopram; oral

1.6

66.5

1893

12365

C01DA14

ATC

isosorbide mononitrate; oral

1.5

66.3

2585

18216

WX110

NOMESCO Finland

Local anesthesy

1.4

66.3

7485

64253

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.3

66.2

664

2992

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

66.0

521

2073

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

65.8

739

3511

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

65.6

2016

13422

N03AX12

ATC

gabapentin; oral

1.7

65.5

1700

10827

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

65.5

2931

21276

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

65.4

418

1465

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.4

65.4

579

2454

N30.0

ICD-10 Finland

Acute cystitis

1.7

65.0

1556

9686

S97

ICPC

Chronic ulcer skin

2.1

64.9

779

3807

N05BA02

ATC

chlordiazepoxide; systemic

3.0

64.4

385

1291

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.3

64.4

248

582

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.5

64.0

234

522

205

Kela drug reimbursment

Chronic hypertension

1.4

63.6

4049

31452

R03AC02

ATC

salbutamol; inhalant

1.4

63.5

5686

46845

K29.2

ICD-10 Finland

Alcoholic gastritis

12.0

63.4

118

A07EA06

ATC

budesonide; oral, local oral

2.9

63.2

406

1428

R60.0

ICD-10 Finland

Localized oedema

1.7

63.1

1414

8629

N06AX21

ATC

duloxetine; oral

1.9

63.0

1041

5759

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

62.8

544

2278

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

62.8

471

1822

UJH02

NOMESCO Finland

Anoscopy

2.5

62.7

532

2204

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

62.6

807

4063

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

62.6

346

1099

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

62.6

441

1642

T90

ICPC

Diabetes non-insulin dependent

1.5

62.5

2809

20375

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

62.4

2835

20608

SPAT1255

SPAT

Intravenous administration of medicine

2.0

62.4

871

4528

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

62.1

939

5031

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

61.9

573

2481

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

61.8

635

2894

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.4

61.5

230

525

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

61.4

2075

14117

B80

ICPC

Iron deficiency anaemia

3.6

61.4

294

837

A07AA11

ATC

rifaximin; oral

28.1

61.3

M10.9

ICD-10 Finland

Gout, unspecified

1.9

61.1

958

5199

R55

ICD-10 Finland

Syncope and collapse

1.7

60.6

1485

9293

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

60.6

5378

44122

R10.0

ICD-10 Finland

Acute abdomen

2.7

60.6

423

1569

WX872

NOMESCO Finland

Intensive care

2.1

60.5

697

3345

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

60.4

3412

25867

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

60.4

594

2652

D64.8

ICD-10 Finland

Other specified anaemias

3.5

60.1

297

867

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

60.0

1556

9890

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

59.8

504

2080

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

59.8

826

4274

A07EA02

ATC

hydrocortisone; rectal

3.2

59.5

328

1040

E86

ICD-10 Finland

Volume depletion

2.7

59.4

423

1587

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

59.2

825

4280

Z71.8

ICD-10 Finland

Other specified counselling

1.5

59.0

2407

17078

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

59.0

4234

33486

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

58.9

3344

25355

A12AA04

ATC

calcium carbonate; oral

3.6

58.5

278

787

ZXA00

NOMESCO Finland

Right side

1.4

58.0

3279

24831

207

Kela drug reimbursment

Chronic arrhythmias

1.5

57.9

2058

14149

127

Kela drug reimbursment

Transplant complication

4.2

57.9

229

552

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

57.9

523

2237

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

57.8

1023

5786

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

57.7

930

5093

R33

ICD-10 Finland

Retention of urine

1.7

57.2

1225

7362

R31

ICD-10 Finland

Unspecified haematuria

1.7

57.2

1445

9111

N19

ICD-10 Finland

Unspecified kidney failure

2.3

57.1

545

2397

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

56.8

728

3655

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

10.5

56.5

112

107

B03XA02

ATC

darbepoetin alfa; parenteral

3.3

56.4

304

949

C09AA05

ATC

ramipril; oral

1.4

56.3

3312

25234

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

56.2

470

1929

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.5

56.2

280

823

WX402

NOMESCO Finland

General anaesthesia

1.6

56.1

1634

10696

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

32.3

56.0

W19

ICD-10 Finland

Unspecified fall

1.7

55.9

1174

7013

EBA00

NOMESCO Finland

Extraction of tooth

1.4

55.9

3495

26920

J01CA04

ATC

amoxicillin; systemic

1.4

55.7

9239

83053

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

55.6

4385

35141

UKC02

NOMESCO Finland

Cystoscopy

1.5

55.4

2250

15921

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

54.8

616

2923

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

54.8

1271

7818

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.3

54.5

535

2387

S18

ICPC

Laceration/cut

1.3

54.3

4820

39330

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

54.2

1083

6369

R03BB04

ATC

tiotropium bromide; inhalant

1.6

53.6

1384

8766

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

53.5

1955

13501

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.8

53.3

232

611

C07AB02

ATC

metoprolol; systemic

1.4

53.1

2898

21732

N06AB03

ATC

fluoxetine; oral

1.7

52.5

1275

7939

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

52.5

1154

6983

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.0

52.3

172

344

K51.8

ICD-10 Finland

Other ulcerative colitis

4.2

52.3

208

505

Z51.5

ICD-10 Finland

Palliative care

1.9

52.0

830

4528

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

51.8

530

2409

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

51.6

421

1707

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

51.4

935

5331

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

51.4

394

1543

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.8

51.1

345

1254

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.1

50.8

204

500

130

Kela drug reimbursment

Malignant tumour

1.7

50.7

1098

6611

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.8

50.6

148

258

A10BA02

ATC

metformin; oral

1.4

50.3

3506

27415

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.9

50.3

215

557

R02

ICPC

Shortness of breath/dyspnoea

1.6

50.2

1382

8898

C05AA08

ATC

fluocortolone; rectal, topical

1.6

50.2

1568

10421

D01

ICPC

Abdominal pain/cramps general

1.7

50.0

1053

6285

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

49.8

551

2595

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

49.8

365

1393

K50.8

ICD-10 Finland

Other Crohn disease

4.1

49.6

202

501

R13

ICD-10 Finland

Dysphagia

1.9

49.5

782

4247

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.5

49.5

409

1671

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

49.4

691

3586

Z72.1

ICD-10 Finland

Alcohol use

4.0

49.1

205

521

D11

ICPC

Diarrhoea

1.7

48.9

1029

6141

K29.8

ICD-10 Finland

Duodenitis

4.7

48.8

170

362

B02AA02

ATC

tranexamic acid; systemic

1.7

48.6

1207

7554

AN1

Coronary angiography

1.5

48.4

1665

11317

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

48.4

1930

13560

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.6

48.3

230

653

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

48.3

587

2882

A01

ICPC

Pain general/multiple sites

1.8

48.1

857

4851

N06AB06

ATC

sertraline; oral

1.7

48.1

996

5915

J01MA14

ATC

moxifloxacin; systemic

1.7

48.0

1029

6177

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

47.9

566

2745

R4190

NOMESCO Finland

Nutritional therapy

2.5

47.9

382

1531

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.8

47.8

209

553

SPAT1260

SPAT

Consultation of another employee

1.5

47.5

2007

14268

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.1

47.5

273

893

ZXA05

NOMESCO Finland

Left side

1.4

47.3

3020

23216

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

47.2

178

411

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.1

47.0

154

307

SPAT1240

SPAT

Therapeutic discussion

1.8

47.0

910

5290

N18.0

ICD-10 Finland

End-stage renal disease

3.7

47.0

216

596

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

47.0

1013

6088

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.1

47.0

190

469

N05AH03

ATC

olanzapine; systemic

2.1

46.9

584

2894

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.9

46.9

157

321

SPAT1216

SPAT

Assessment of functional ability

1.5

46.8

1937

13706

R04.2

ICD-10 Finland

Haemoptysis

2.2

46.8

492

2263

C09AA02

ATC

enalapril; systemic

1.4

46.8

2666

20082

N05CF02

ATC

zolpidem; oral

1.5

46.8

1699

11683

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

46.8

1041

6312

Z94.4

ICD-10 Finland

Liver transplant status

11.3

46.8

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

46.7

288

987

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.6

46.7

223

635

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

46.5

900

5231

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

46.4

1329

8635

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

46.2

282

961

K59.0

ICD-10 Finland

Constipation

1.9

46.2

731

3970

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

46.2

702

3761

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

46.1

538

2594

X58

ICD-10 Finland

Exposure to other specified factors

1.6

46.0

1388

9136

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.6

45.6

353

1391

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

4.0

45.6

188

473

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.6

45.3

335

1287

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

45.3

917

5405

L04AA06

ATC

mycophenolic acid; systemic

3.5

45.3

223

651

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.4

45.2

170

392

UJG02

NOMESCO Finland

Proctoscopy

2.8

45.2

299

1073

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

44.5

1678

11627

SPAT1229

SPAT

Assessment of need for aid

1.7

44.5

1016

6207

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

44.3

1502

10160

SPAT1265

SPAT

Breathalyser

4.6

44.3

159

350

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

44.0

224

671

RD210

NOMESCO Finland

3.4

44.0

226

682

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

+∞

43.8

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

9.3

43.7

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

43.7

491

2330

N03AX09

ATC

lamotrigine; oral

2.3

43.6

407

1771

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

43.4

211

610

K83.0

ICD-10 Finland

Cholangitis

3.3

43.4

231

716

N06AA09

ATC

amitriptyline; systemic

1.6

43.3

1087

6814

B01AB04

ATC

dalteparin; parenteral

2.0

43.3

614

3204

WX704

NOMESCO Finland

Intubation

1.8

43.2

748

4191

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

43.1

776

4404

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

43.0

475

2235

N06AA12

ATC

doxepin; systemic

1.9

43.0

646

3446

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

6.5

42.8

114

177

E0000UV

ATC

1.3

42.7

4138

33875

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.7

42.6

150

324

WX730

NOMESCO Finland

Conventional respirator

3.0

42.6

258

875

K65.0

ICD-10 Finland

Acute peritonitis

3.6

42.4

196

544

K70.0

ICD-10 Finland

Alcoholic fatty liver

5.1

42.4

137

270

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

42.4

243

794

WZC30

NOMESCO Finland

Teaching

1.5

42.2

1386

9296

SPAT1252

SPAT

Overall medication plan or its review

1.7

42.2

887

5285

JJC00

NOMESCO Finland

Allogenic transplantation of liver

14.8

42.2

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

11.7

42.2

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

42.0

822

4790

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

42.0

1078

6798

H02AB07

ATC

prednisone; oral

1.5

41.9

1612

11210

G44.2

ICD-10 Finland

Tension-type headache

1.6

41.7

1170

7552

K30

ICD-10 Finland

Functional dyspepsia

1.7

41.6

1004

6225

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

41.3

730

4117

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

41.2

290

1082

S01.0

ICD-10 Finland

Open wound of scalp

1.7

41.2

939

5727

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.3

41.0

112

180

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

40.9

836

4938

A07AA09

ATC

vancomycin; oral

3.4

40.8

203

598

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

40.8

688

3819

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

40.8

763

4384

N05AX08

ATC

risperidone; systemic

1.7

40.6

990

6155

JDH25

NOMESCO Finland

Other endoscopic haemostatic procedure in duodenum

24.9

40.5

L04AD01

ATC

ciclosporin; systemic

3.2

40.4

225

721

J01EA01

ATC

trimethoprim; systemic

1.4

40.4

2684

20689

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.7

40.3

291

1101

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

13.2

40.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

40.2

1590

11116

N05AF03

ATC

chlorprothixene; systemic

2.6

40.2

300

1160

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.7

40.0

182

499

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

40.0

535

2727

D14

ICPC

Haematemesis/vomiting blood

19.1

39.9

A10BH01

ATC

sitagliptin; oral

1.6

39.6

1143

7426

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

6.3

39.5

107

170

SPAT1104

SPAT

Monitoring of emergency patient

1.7

39.5

796

4682

PD1CD

NOMESCO Finland

Very extensive CT of abdominal aorta and branches

6.9

39.5

100

145

A10BB12

ATC

glimepiride; oral

1.6

39.4

1058

6747

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

9.9

39.4

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

39.4

4274

35442

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

39.3

3121

24732

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

39.3

3086

24414

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.5

39.1

316

1274

C07AG02

ATC

carvedilol; oral

1.7

39.1

803

4749

JAH01

NOMESCO Finland

Laparoscopy

2.2

39.1

408

1873

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

7.3

39.1

130

E000001

ATC

1.4

39.0

2123

15796

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

38.9

153

369

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

38.9

606

3272

K85

ICD-10 Finland

Acute pancreatitis

2.8

38.8

263

961

I81

ICD-10 Finland

Portal vein thrombosis

7.2

38.7

132

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

12.8

38.6

V03AE01

ATC

polystyrene sulfonate; oral

3.2

38.6

209

657

A41.8

ICD-10 Finland

Other specified sepsis

2.8

38.3

259

943

S22.3

ICD-10 Finland

Fracture of rib

1.7

38.3

783

4626

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

4.0

38.2

156

390

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

38.0

338

1437

UJK02

NOMESCO Finland

ERCP

2.4

37.9

341

1458

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

37.8

3743

30604

J01AA02

ATC

doxycycline; systemic

1.3

37.8

8987

82148

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

37.8

846

5134

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

37.7

774

4576

N03AG01

ATC

valproic acid; systemic, rectal

1.9

37.6

619

3407

R07.3

ICD-10 Finland

Other chest pain

1.6

37.4

1016

6497

N05BA12

ATC

alprazolam; oral

1.6

37.4

1027

6588

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

7.7

37.3

115

I86.4

ICD-10 Finland

Gastric varices

26.9

37.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

37.1

460

2275

X57

ICD-10 Finland

Unspecified privation

2.6

37.1

282

1100

K56.7

ICD-10 Finland

Ileus, unspecified

2.8

36.8

251

920

A12BA01

ATC

potassium chloride; oral

1.8

36.7

712

4138

WVA20

NOMESCO Finland

Medicine administration

2.6

36.7

276

1070

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

36.5

392

1822

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

36.5

590

3226

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.5

36.5

178

518

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

36.3

766

4563

A10AE05

ATC

insulin detemir; parenteral

1.8

36.3

638

3589

K29.1

ICD-10 Finland

Other acute gastritis

3.2

36.3

199

632

D50

ICD-10 Finland

Iron deficiency anaemia

3.0

35.8

214

722

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.5

35.6

145

SPAT1097

SPAT

Recording of ECG

1.4

35.5

1695

12281

C01AA05

ATC

digoxin; systemic

1.5

35.5

1317

9063

A07AA02

ATC

nystatin; oral

1.7

35.4

713

4190

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

35.4

1091

7200

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

35.3

342

1517

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

4.4

35.2

132

305

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

35.1

485

2506

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

34.9

544

2936

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

34.9

1102

7313

L01BC06

ATC

capecitabine; oral

2.1

34.8

393

1871

Z00.0

ICD-10 Finland

General medical examination

1.4

34.7

1966

14702

V03AA01

ATC

2.8

34.5

231

837

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

34.5

496

2601

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

34.4

674

3927

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.9

34.3

100

RS220

NOMESCO Finland

3.4

34.1

172

514

N17.8

ICD-10 Finland

Other acute renal failure

3.3

34.0

178

547

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

65.1

34.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

33.9

270

1082

SPAT1234

SPAT

Support of social functional capacity

1.8

33.9

646

3731

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

33.9

202

679

A29

ICPC

General symptom/complaint other

1.5

33.8

1227

8401

N03AE01

ATC

clonazepam; systemic

1.8

33.8

603

3409

Z93.3

ICD-10 Finland

Colostomy status

4.4

33.7

125

286

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

33.6

869

5482

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

33.5

619

3541

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

33.4

2894

23135

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

33.4

477

2495

L17

ICPC

Foot/toe symptom/complaint

1.3

33.3

2579

20274

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

33.3

785

4828

C10AC01

ATC

colestyramine; oral

2.5

33.2

277

1140

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

33.1

381

1828

N07BA03

ATC

varenicline; oral

2.0

33.1

428

2152

D10

ICPC

Vomiting

2.0

33.1

450

2311

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

33.0

1471

10510

N05BE01

ATC

buspirone; oral

2.3

32.9

307

1337

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

32.8

927

5981

N05AX12

ATC

aripiprazole; systemic

2.4

32.8

297

1273

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

32.8

485

2571

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.9

32.8

209

736

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

32.8

219

795

A02BDXX

ATC

2.0

32.7

442

2264

K22.7

ICD-10 Finland

Barrett oesophagus

3.2

32.7

174

542

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.7

32.5

146

398

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

32.5

243

940

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.4

32.5

120

274

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.9

32.4

136

350

P76

ICPC

Depressive disorder

1.9

32.1

461

2418

D07AC01

ATC

betamethasone; topical

1.3

32.1

3596

29753

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

20.1

32.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

32.0

1475

10604

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.8

32.0

213

771

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.6

31.7

145

402

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

31.6

450

2350

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

31.6

298

1306

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

15.3

31.5

J01CA08

ATC

pivmecillinam; oral

1.3

31.5

3427

28232

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

31.5

822

5198

P01

ICPC

Feeling anxious/nervous/tense

1.7

31.5

716

4360

N05AB01

ATC

dixyrazine; systemic

3.1

31.5

177

574

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.2

31.3

123

298

XF404

NOMESCO Finland

Ambulatory ECG

1.5

31.3

1056

7109

I50

ICD-10 Finland

Heart failure

1.9

31.2

459

2428

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

31.0

1570

11484

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

30.9

234

913

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.7

30.9

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

30.9

4015

33817

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

9.9

30.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

30.7

1724

12851

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

30.6

523

2915

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

30.6

603

3517

H02AB04

ATC

methylprednisolone; systemic

1.4

30.6

1490

10817

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.7

30.6

209

769

D18

ICPC

Change in faeces/bowel movements

2.5

30.5

243

977

RS221

NOMESCO Finland

3.0

30.5

182

613

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

30.5

255

1052

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

30.4

2702

21637

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

30.3

752

4687

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

30.3

234

924

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

30.3

939

6196

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.2

30.3

323

1499

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

30.2

3351

27648

G04CA02

ATC

tamsulosin; oral

1.3

30.2

3316

27326

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.8

30.1

148

J02AC01

ATC

fluconazole; systemic

1.3

30.1

3280

26997

I20.09

ICD-10 Finland

Unstable angina

1.6

30.1

772

4856

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.7

29.9

213

803

1370

FHL

Colonoscopy, whole colon

4.6

29.8

106

234

C10AA01

ATC

simvastatin; oral

1.2

29.8

5515

48335

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.8

29.6

127

334

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.3

29.5

286

1268

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

29.5

1048

7134

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.6

29.5

221

857

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

3.8

29.5

128

340

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.2

29.5

303

1385

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.8

29.4

206

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

6.4

29.4

122

SPAT1312

SPAT

General health counselling

1.3

29.3

3270

26981

B01AF02

ATC

apixaban; oral

1.5

29.3

1168

8151

N06AX03

ATC

mianserin; oral

1.8

29.1

510

2865

R52.9

ICD-10 Finland

Pain, unspecified

1.6

29.1

817

5260

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

29.1

608

3610

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

29.1

603

3575

K29.6

ICD-10 Finland

Other gastritis

3.1

29.0

161

518

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

29.0

1680

12575

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.7

29.0

101

218

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.3

29.0

272

1190

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

29.0

232

935

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.6

29.0

211

807

K72.1

ICD-10 Finland

Chronic hepatic failure

11.0

28.9

K76.7

ICD-10 Finland

Hepatorenal syndrome

10.6

28.8

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.9

28.8

198

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.7

28.6

206

783

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

18.4

28.6

I50.1

ICD-10 Finland

Left ventricular failure

1.7

28.6

684

4224

K02.1

ICD-10 Finland

Caries of dentine

1.2

28.5

5409

47450

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

28.5

423

2246

A10BH05

ATC

linagliptin; oral

1.7

28.4

602

3590

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.5

28.4

229

927

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.5

28.4

137

397

K08.3

ICD-10 Finland

Retained dental root

1.6

28.4

740

4675

P03

ICPC

Feeling depressed

1.7

28.4

657

4020

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

28.3

139

409

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

28.2

141

420

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

28.2

504

2852

SPAT1310

SPAT

Counselling related to known health issue

1.3

28.2

3324

27588

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.2

28.2

110

266

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

28.1

1163

8172

A03

ICPC

Fever

1.4

27.9

1321

9530

WW200

NOMESCO Finland

Immunization

2.2

27.9

294

1360

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

27.9

2692

21769

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

27.8

4587

39590

S70.0

ICD-10 Finland

Contusion of hip

1.9

27.8

428

2304

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

27.8

187

682

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

27.8

1425

10436

N06AB05

ATC

paroxetine; oral

1.8

27.8

520

2987

M25.5

ICD-10 Finland

Pain in joint

1.3

27.7

2512

20132

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

27.5

176

622

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

27.5

223

906

K78

ICPC

Atrial fibrillation/flutter

1.5

27.4

1004

6875

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

27.4

531

3081

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.4

27.4

100

227

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

27.3

2346

18657

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

27.3

458

2537

A04AA01

ATC

ondansetron; systemic, rectal

1.7

27.2

629

3844

D02

ICPC

Abdominal pain epigastric

1.8

27.2

511

2936

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

27.2

1961

15198

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

27.1

650

4016

D09

ICPC

Nausea

2.0

27.1

360

1831

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.2

27.1

105

252

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

27.1

1725

13106

JFB30

NOMESCO Finland

Right hemicolectomy

2.6

27.1

207

814

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

27.1

149

477

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

6.6

27.1

106

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.5

27.1

216

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.8

27.0

117

311

RS222

NOMESCO Finland

2.9

27.0

168

584

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

27.0

293

1374

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

26.9

468

2624

K51

ICD-10 Finland

Ulcerative colitis

4.0

26.9

109

273

D07AA02

ATC

hydrocortisone; topical

1.4

26.9

1295

9373

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

26.8

641

3960

JKA20

NOMESCO Finland

Cholecystectomy

2.0

26.6

358

1831

PC4SC

NOMESCO Finland

Bowel angiography with X-ray

12.7

26.5

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

26.4

449

2500

TK810

NOMESCO Finland

Hemofiltration

4.3

26.4

231

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

26.4

972

6664

E66.8

ICD-10 Finland

Other obesity

1.9

26.3

389

2064

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

26.3

961

6580

JF2BD

NOMESCO Finland

Extensive colon CT

3.3

26.3

133

401

D06

ICPC

Abdominal pain localized other

1.6

26.2

701

4459

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

26.2

891

6006

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

26.0

292

1389

C08CA13

ATC

lercanidipine; oral

1.4

25.9

1450

10775

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

25.9

422

2317

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

25.9

151

504

A02BA03

ATC

famotidine; systemic

1.8

25.9

490

2825

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.6

25.9

199

786

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

25.8

597

3651

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.1

25.8

165

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

25.8

506

2950

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

25.6

4550

39492

M01AB55

ATC

diclofenac, combinations; oral

1.6

25.6

766

5010

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

25.5

543

3241

S10

ICPC

Boil/carbuncle

1.7

25.4

516

3037

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2363

10450

2.50

320.31

3.5

2.4

43.4

49.3

u/l

0.25

2072

8902

(3014111) Lactate [Moles/volume] in Serum or Plasma

2480

11288

2.43

315.29

8.5

6.6

1.5

1.4

mmol/l

3.30

2389

10790

(3013826) Glucose [Moles/volume] in Serum or Plasma

9526

70875

1.94

313.23

8.4

4.8

7.0

6.8

mmol/l

9.35

9175

66361

(3000991) Gas panel - Venous blood

2392

10753

2.46

312.32

10.8

7.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8478

60819

1.90

310.49

11.2

6.6

1.2

mmol/l

41.36

7275

50794

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5753

35300

2.02

307.65

5.1

3.1

38.4

35.4

u/l

1.52

5434

33194

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7387

46772

2.14

307.65

4.5

2.8

135.6

151.9

ug/l

3.95

6816

42535

(3032080) INR in Blood by Coagulation assay

8140

51640

2.25

307.65

14.6

10.2

1.3

inr

0.71

2380

14213

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3859

19551

2.31

307.65

4.7

3.2

0.8

mmol/l

20.96

3599

18079

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3372

16298

2.38

307.65

8.5

5.7

1.1

1.0

mmol/l

5.26

3170

14982

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5045

28225

2.18

307.65

3.9

2.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4273

19699

2.63

307.65

3.6

2.5

10.9

12.6

umol/l

37.86

4011

18034

(3014576) Chloride [Moles/volume] in Serum or Plasma

3336

15974

2.40

307.65

9.5

6.7

104.4

104.5

mmol/l

0.27

3259

15610

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6143

31667

2.59

307.65

3.3

2.2

3.5

3.0

mg/l

32.93

5450

26666

(3020779) Urea [Moles/volume] in Serum or Plasma

2640

11634

2.54

307.65

10.4

6.8

11.7

10.8

mmol/l

6.99

2500

10949

(3023183) Ammonium ion [Moles/volume] in Plasma

1082

2409

4.76

307.65

4.8

2.3

39.5

32.3

umol/l

11.35

947

1972

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8203

53592

2.17

307.65

6.4

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

6512

37110

2.33

307.65

4.1

2.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2609

10768

2.72

307.65

3.3

2.1

0.2

g/l

23.00

2385

9917

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2715

12272

2.48

307.65

5.9

3.9

5.8

kpa

1.27

2624

11897

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6814

36307

2.60

307.65

3.9

2.5

58.6

59.1

u/l

0.18

6481

33323

(3012544) pH of Venous blood

2773

12699

2.45

307.65

5.9

3.9

7.4

0.11

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4038

18249

2.66

307.65

3.6

2.5

2.3

g/l

2.85

3771

16719

(3027945) Reticulocytes/100 erythrocytes in Blood

3224

15259

2.42

307.65

2.9

2.4

2.0

1.7

33.18

2855

13308

(3024561) Albumin [Mass/volume] in Serum or Plasma

8187

52454

2.23

307.65

8.3

4.6

33.3

34.9

g/l

96.06

7717

48175

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9560

60891

2.56

307.65

9.7

5.9

13.0

12.3

umol/l

2.41

9200

57492

(3002032) Base excess in Venous blood by calculation

2695

12255

2.46

307.65

6.0

3.9

1.6

1.9

mmol/l

2.14

2198

9899

(40768797) Stomach Pathology biopsy report

3582

14471

2.94

307.65

1.5

1.2

—

(3023368) Bacteria identified in Blood by Culture

6167

36124

2.20

307.65

6.2

4.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9052

65581

1.95

307.65

11.6

8.6

4.6

4.3

e9/l

15.91

8131

56596

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2342

8903

2.93

307.65

2.1

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3825

17127

2.65

307.65

3.7

2.5

19.5

22.3

22.28

3323

14400

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2865

12900

2.51

307.65

4.6

2.7

12.0

9.2

umol/l

4.14

2522

11166

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3589

19350

2.12

301.85

3.1

2.1

30.9

30.1

9.65

3480

18786

(3003396) Base excess in Arterial blood by calculation

2955

14881

2.23

294.83

9.3

6.8

1.0

mmol/l

0.09

2319

11547

(3016502) Oxygen saturation in Arterial blood

2722

13333

2.27

290.07

9.6

7.1

95.2

95.4

0.75

2634

12795

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2943

14890

2.21

289.74

9.4

6.8

5.0

5.1

kpa

3.82

2808

14118

(3027801) Oxygen [Partial pressure] in Arterial blood

2940

14881

2.21

289.07

9.4

6.8

11.5

12.0

kpa

6.27

2806

14086

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11206

89218

2.00

287.65

12.7

7.3

88.0

80.3

u/l

28.79

10795

83426

(3033658) Prothrombin time (PT) actual/Normal

4864

29794

1.93

282.65

8.1

3.9

81.7

85.5

18.52

4737

29096

(3006315) Basophils [#/volume] in Blood

7952

56943

1.84

281.61

7.7

5.7

0.0

e9/l

0.44

7033

48498

(3024354) Oxygen [Partial pressure] in Venous blood

2225

10126

2.40

280.48

5.1

3.3

4.6

4.5

kpa

0.68

2139

9762

(3023520) Reticulocytes [#/volume] in Blood

2415

11407

2.33

279.57

2.9

2.5

75.0

67.6

e9/l

14.26

1858

8657

(3001604) Monocytes [#/volume] in Blood

7907

56630

1.83

278.77

7.7

5.6

0.6

e9/l

8.50

6977

48200

(3013115) Eosinophils [#/volume] in Blood

8126

58714

1.83

278.05

8.0

5.9

0.2

e9/l

0.99

7249

50748

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7750

55257

1.83

276.38

10.4

6.0

1.2

mmol/l

46.66

7183

49594

(3022145) Colonoscopy Study observation

2476

11883

2.30

275.80

1.5

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

8028

58198

1.81

267.58

7.8

5.7

1.8

1.9

e9/l

6.04

7189

50462

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1565

6151

2.72

267.53

1.8

1.6

1.5

1.6

g/l

3.10

1354

5184

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2855

14800

2.15

261.53

4.3

4.0

245.7

248.1

u/l

0.33

2684

13864

(3019069) Monocytes/100 leukocytes in Blood

7516

53676

1.80

260.95

8.4

6.2

9.0

8.8

5.67

7099

49732

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2464

12060

2.25

260.59

10.1

7.5

113.6

121.8

g/l

61.13

2411

11616

(3022096) Basophils/100 leukocytes in Blood

7311

51852

1.80

259.22

8.0

5.9

0.6

1.31

6896

47915

(3006504) Eosinophils/100 leukocytes in Blood

7471

53369

1.79

258.12

8.0

5.9

2.8

2.41

7041

49269

(3026008) Bacteria identified in Urine by Culture

5621

36950

1.83

255.90

4.2

3.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

994

3142

3.32

249.95

3.7

2.8

3.3

3.6

g/l

8.90

938

2991

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3701

21416

1.96

249.06

2.2

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

7588

54918

1.77

246.36

8.2

6.0

24.3

26.7

61.94

7131

50600

(42870588) Differential panel, method unspecified - Blood

5879

39630

1.79

242.75

7.4

5.8

—

(3018010) Neutrophils/100 leukocytes in Blood

7470

53998

1.76

241.93

7.9

5.8

60.0

58.2

31.96

7040

49975

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1492

6232

2.55

223.78

6.6

4.2

23.8

24.1

mmol/l

2.96

1360

5589

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2439

12589

2.12

222.55

4.1

3.9

18.0

24.8

ug/l

0.89

2056

10395

(3042936) Bacteria identified in Isolate by Culture

3067

17257

1.98

220.35

2.8

2.0

—

(3026782) Osmolality of Urine

4054

25044

1.85

218.63

3.8

2.9

529.7

558.3

mosm/kgh2o

14.30

3573

21261

(3002582) Erythrocytes [#/volume] in Urine

5602

38141

1.75

216.85

4.5

3.4

81.5

112.3

e6/l

0.76

4606

29511

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6681

47815

1.71

215.47

5.6

4.0

53.1

79.0

ng/l

1.15

5237

35411

(3019309) Folate [Moles/volume] in Red Blood Cells

4138

25875

1.83

213.67

2.0

1.8

1226.1

1156.5

nmol/l

4.31

3222

19228

(3022217) INR in Platelet poor plasma by Coagulation assay

3193

18402

1.93

212.86

29.5

29.1

1.5

inr

0.14

457

2470

(3031040) Bacteria [#/volume] in Urine by Automated count

9793

77903

1.73

212.19

6.5

4.7

828.4

1435.0

e6/l

1.18

177

1293

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1041

3768

2.89

206.30

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1190

4688

2.67

200.39

4.4

3.0

0.3

0.4

u/ml

5.92

720

2651

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2668

14745

1.98

199.74

2.2

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1708

8009

2.28

196.55

11.3

8.6

93.1

93.9

3.89

1698

7979

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2655

14758

1.97

195.01

2.1

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

2212

11524

2.08

194.77

3.5

2.2

207.2

145.4

ug/g

7.50

1850

8959

(3004119) Hemoglobin [Mass/volume] in Venous blood

1672

7809

2.28

194.12

4.9

3.4

118.3

129.0

g/l

55.52

1632

7611

(3000850) Epithelial cells [#/volume] in Urine

4157

26676

1.77

193.20

3.5

2.7

5.3

4.8

e6/l

1.96

3739

23325

(3030467) Casts [#/volume] in Urine by Automated count

5103

34847

1.70

188.82

4.4

3.3

0.6

0.5

e6/l

1.35

4135

26491

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

565

1480

3.93

187.95

3.1

2.6

2309.7

793.4

u/ml

0.44

548

1431

(3018418) pH of Serum or Plasma

5205

35812

1.69

186.76

6.2

4.0

7.4

0.22

1059

6817

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1685

8026

2.24

186.17

11.3

8.5

0.7

0.36

1671

7965

(3018095) Leukocytes [#/volume] in Urine

6054

43397

1.66

185.18

5.1

3.9

144.9

105.7

e6/l

1.54

4791

31452

(3021960) Folate [Moles/volume] in Serum or Plasma

4452

29507

1.72

182.52

1.8

1.6

19.7

19.9

nmol/l

0.21

3953

25075

(3007853) Bacteria identified in Skin by Aerobe culture

2526

14119

1.95

181.25

2.2

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1369

6037

2.39

180.95

3.9

2.9

1.4

1.2

5.11

1364

6004

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1672

8049

2.21

179.63

11.2

8.4

1.5

1.4

4.60

1659

7988

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6830

50889

1.63

176.24

2.4

2.1

91.3

93.6

pmol/l

3.51

3943

26982

(36304419) Bacteria [Presence] in Urine

4891

33498

1.68

176.12

4.3

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2143

11448

2.02

174.66

2.5

1.7

1.5

23.15

1801

9832

(40758558) Short blood count panel - Blood

4330

28758

1.71

174.66

9.0

6.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3822

24569

1.74

173.25

5.5

4.0

415.2

512.9

ng/l

0.52

3178

20422

(3017143) Hepatitis C virus Ab [Presence] in Serum

2026

10649

2.04

172.59

1.8

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5499

39053

1.64

170.56

4.0

3.2

2408.9

1773.4

ng/l

11.11

4819

33682

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1326

5913

2.36

170.51

4.0

2.9

0.7

2.58

1297

5669

(3007566) Smooth muscle Ab [Titer] in Serum

771

2637

3.03

168.52

1.4

1.2

88.0

148.8

titre

1.24

216

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5293

37353

1.64

167.61

2.6

2.1

228.8

232.3

u/l

0.09

5016

34847

(3019060) Gas panel - Arterial blood

1742

8772

2.11

166.14

6.6

4.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1570

7624

2.18

164.30

1.7

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

759

2631

2.98

161.91

1.3

1.2

645.0

907.1

titre

0.48

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1436

6828

2.22

158.09

12.5

9.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1567

7742

2.14

156.55

10.3

7.2

24.5

24.7

mmol/l

1.68

1557

7655

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3720

24351

1.70

155.00

2.7

1.7

1.4

mg/l

0.23

2961

18767

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

854

3245

2.73

153.42

3.8

2.7

86.2

89.5

3.04

798

3053

(3037467) Urinalysis macro (dipstick) panel - Urine

9717

80339

1.59

150.81

6.1

4.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1010

4208

2.50

150.32

3.3

1501.4

2199.9

u/ml

0.35

867

3614

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1612

8210

2.08

148.25

9.7

6.6

24.1

24.6

mmol/l

4.06

1540

7647

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

783

2926

2.77

145.14

4.4

2.6

206.6

198.0

1.55

748

2776

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8669

70238

1.55

143.39

5.6

3.0

77.7

52.2

u/l

47.31

8122

64398

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2208

12707

1.86

141.78

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1805

9720

1.97

141.73

2.3

2.2

377.1

nmol/l

0.00

1675

8852

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1396

6847

2.14

141.45

11.3

8.7

24.1

24.2

mmol/l

0.48

1301

6308

(3036489) Thrombin time

958

4037

2.47

138.87

3.4

2.2

23.0

21.7

3.10

856

3583

(3027273) Bicarbonate [Moles/volume] in Venous blood

1326

6428

2.16

138.32

5.0

3.4

24.8

25.1

mmol/l

2.46

1289

6234

(3028026) IgM [Mass/volume] in Serum or Plasma

1293

6227

2.18

137.09

1.7

1.9

1.4

g/l

0.04

1186

5596

(3005719) IgG [Mass/volume] in Serum or Plasma

1542

7948

2.05

136.71

2.6

2.7

11.1

10.6

g/l

3.72

1406

7215

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

271

513

5.36

135.10

4.0

2.3

91.7

96.0

0.97

259

485

(3023487) Leukocytes [#/volume] in Peritoneal fluid

232

379

6.20

135.08

2.5

2.0

2512.6

3205.3

e6/l

0.09

174

255

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1165

5413

2.25

134.90

2.2

1.9

2.5

2.1

ug/l

0.30

1027

4697

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1018

4483

2.36

133.67

2.8

2.3

776.5

598.4

ug/l

0.39

972

4222

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6010

45473

1.53

132.13

2.9

2.2

75.6

77.8

nmol/l

6.73

5358

39985

(3000570) Elastase.pancreatic [Mass/mass] in Stool

798

3185

2.59

129.56

1.5

1.4

250.4

272.8

ug/g

2.02

479

1904

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

212

336

6.38

127.19

2.2

1.9

7848.9

13347.7

e6/l

0.37

135

177

(3033799) Differential panel - Peritoneal fluid

215

348

6.25

126.34

2.4

1.8

—

(3025941) Bacteria identified in Stool by Culture

1211

5875

2.15

125.63

1.5

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

1009

4572

2.29

123.75

5.4

3.8

1.6

1.4

mmol/l

3.41

986

4487

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1215

5948

2.13

123.05

5.8

4.1

47.8

47.6

0.10

1204

5876

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

847

3574

2.45

122.10

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

188

278

6.83

120.54

1.9

1.4

10.0

14.1

g/l

6.99

135

220

(3015377) Calcium [Moles/volume] in Serum or Plasma

5340

40069

1.52

118.27

3.9

3.3

2.3

2.4

mmol/l

17.08

4661

34231

(3021589) Normoblasts [#/volume] in Blood

6408

49952

1.49

117.74

16.9

9.9

0.0

e9/l

0.45

5390

40587

(3013707) Erythrocyte sedimentation rate by Westergren method

9842

83714

1.51

116.44

5.3

4.1

17.1

13.3

mm/h

73.50

9132

76566

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3044

20157

1.64

116.30

3.8

3.1

2.8

2.1

e6/l

3.14

1803

11178

(3007164) IgA [Mass/volume] in Serum or Plasma

2879

18862

1.65

114.53

1.5

3.0

2.6

g/l

12.97

1835

11073

(3020191) Ethanol [Moles/volume] in Serum or Plasma

331

842

4.00

114.47

2.1

1.3

1.5

1.3

promille

1.68

250

643

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

742

3045

2.51

113.43

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

494

1641

3.08

113.17

7.2

6.2

12.3

11.7

mg/l

1.74

443

1478

(3044007) Cell count panel - Peritoneal fluid

190

305

6.29

112.58

2.2

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1628

9127

1.88

111.67

5.4

3.8

116.2

95.0

ng/l

9.68

1400

7702

(3020630) Protein [Mass/volume] in Serum or Plasma

1861

10893

1.81

111.05

2.3

2.5

65.2

66.1

g/l

5.39

1695

9710

(3024928) Oxygen saturation in Venous blood

660

2588

2.62

110.85

4.1

3.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3174

21490

1.60

109.89

3.5

2.9

1.3

e6/l

0.05

1934

12432

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1261

6521

2.02

109.73

2.7

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

587

2197

2.74

108.09

6.3

5.6

612.7

1752.0

iu/ml

0.82

340

(40760892) CBC W Ordered Manual Differential panel - Blood

3408

23547

1.58

107.95

5.7

4.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4337

31630

1.52

107.49

3.5

2.8

4406.7

5437.5

umol/l

0.87

3733

26927

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1984

11953

1.76

107.02

3.0

2.4

6.5

7.3

ug/l

0.96

1735

10169

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1536

8572

1.88

106.60

6.2

3.8

5.1

kpa

3.86

1417

7872

(3009343) pH of Capillary blood

1516

8468

1.88

104.83

6.2

3.8

7.4

0.11

237

1053

(3020891) Body temperature

1044

5155

2.10

102.80

7.3

4.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3723

26496

1.54

102.46

1.9

1.7

13850082.1

25926005.2

pmol/l

1.03

3112

21473

(3037522) Nuclear Ab [Titer] in Serum

2152

13415

1.70

102.33

1.4

1.3

423.6

520.7

titre

2.30

443

2789

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1464

8198

1.87

100.22

6.2

3.8

1.6

1.8

mmol/l

1.45

1070

6002

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1920

11724

1.73

98.12

4.0

3.1

308.4

244.2

ng/l

5.10

1775

10679

(3035350) Ketones [Presence] in Urine by Test strip

6935

56267

1.43

96.24

5.0

3.8

0.0

estimate

1.34

1496

10350

(3002331) Protein [Mass/volume] in Peritoneal fluid

157

247

6.41

94.91

1.4

1.3

21.1

55.9

g/l

0.81

116

191

(3021601) Nitrite [Presence] in Urine by Test strip

6907

56250

1.42

92.47

6.7

5.1

0.0

estimate

0.80

1518

10523

(3007930) Methemoglobin/Hemoglobin.total in Blood

1033

5279

2.03

92.39

7.2

5.0

0.9

0.60

983

4945

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1044

5363

2.02

92.02

7.2

5.0

1.8

1.6

4.61

991

5026

(1616796) Gas panel - Central venous blood

685

2983

2.36

91.63

4.7

3.6

—

(3009261) Glucose [Presence] in Urine by Test strip

6967

56925

1.42

91.01

5.0

3.9

0.0

estimate

2.12

1464

10209

(46235355) HIV 1 and 2 tests - Meaningful Use set

2331

15316

1.62

89.20

2.0

1.8

—

(3015736) pH of Urine

5619

44303

1.43

89.14

4.5

3.6

5.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2030

12912

1.66

88.37

5.2

3.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

720

3270

2.26

87.23

6.6

3.5

8.2

8.1

kpa

0.49

664

3047

(3052851) Hemolysis interference index of Serum or Plasma

800

3799

2.17

86.82

4.4

3.4

—

(3047181) Lactate [Moles/volume] in Blood

813

3904

2.14

85.74

8.2

5.9

1.5

1.3

mmol/l

5.00

726

3448

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2995

21074

1.53

84.34

1.3

1.2

1.6

1.3

u/ml

0.66

733

5258

(3043409) Potassium [Moles/volume] in Arterial blood

814

3937

2.13

84.24

6.0

4.0

3.9

mmol/l

0.05

751

3685

(44816559) Phosphatidylethanol [Mass/volume] in Blood

471

1789

2.68

84.15

1.9

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

1617

9826

1.72

83.21

4.6

4.0

0.9

0.10

587

2899

(3019230) Fractional oxyhemoglobin in Venous blood

513

2047

2.56

82.94

4.3

3.1

61.5

63.7

1.20

508

2036

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

775

3723

2.14

81.58

2.1

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

732

3460

2.17

80.29

4.2

3.2

24.3

24.8

mmol/l

1.82

640

3051

(3009445) Proteinase 3 Ab [Units/volume] in Serum

964

5078

1.96

78.76

1.4

1.6

15.8

16.6

u/ml

0.05

134

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1365

8030

1.77

78.54

2.0

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12375

113441

1.51

77.26

32.3

15.7

26.2

26.6

mg/l

0.60

11288

91791

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

563

2432

2.37

76.58

1.5

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

378

1347

2.85

76.29

1.1

1.6

1.5

g/l

2.92

344

1204

(3010421) pH of Blood

719

3443

2.14

76.24

6.4

4.0

7.4

2.29

619

2941

(3002179) Metamyelocytes/100 leukocytes in Blood

1462

8903

1.71

74.20

4.3

3.9

0.7

0.13

407

2092

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

626

2867

2.23

74.19

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

437

4.34

73.40

3.5

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

268

808

3.36

72.09

1.5

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

206

520

4.00

72.07

7.4

4.0

72.7

553.2

mg/l

0.53

158

362

(3021901) Oxygen saturation in Capillary blood

567

2538

2.28

70.98

3.5

2.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

651

3087

2.16

70.72

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

604

2780

2.22

70.69

3.3

2.5

15.5

16.1

2.73

329

1476

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1188

6932

1.77

69.98

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

650

3099

2.15

69.63

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3103

22786

1.46

68.72

3.6

3.1

2.5

mmol/l

3.32

2645

19706

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

625

2950

2.17

68.68

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

640

3061

2.14

67.99

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1451

9025

1.67

67.71

2.1

2.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

623

2971

2.14

66.67

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

623

2972

2.14

66.61

1.6

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

632

3038

2.13

66.25

6.6

4.0

8.5

kpa

0.01

618

2951

(3012501) Base excess in Blood by calculation

629

3025

2.13

65.85

6.6

4.0

2.6

mmol/l

0.17

454

2033

(3013290) Carbon dioxide [Partial pressure] in Blood

629

3027

2.12

65.74

6.6

4.0

5.0

kpa

0.11

615

2941

(3021440) Promyelocytes/100 leukocytes in Blood

1485

9364

1.65

65.60

4.7

4.0

0.1

0.29

533

2703

(3006184) Hemoglobin [Mass/volume] in Capillary blood

616

2952

2.13

65.08

2.7

2.2

122.5

128.6

g/l

6.51

491

2161

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

813

4312

1.94

64.84

2.5

3.2

48.6

48.7

mg/l

0.01

652

3477

(3010375) cycloSPORINE [Mass/volume] in Blood

186

471

3.98

64.82

31.8

27.3

115.0

115.7

ug/l

0.05

157

395

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

476

2058

2.36

64.57

1.7

1.4

18.9

15.8

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

478

2073

2.35

64.39

1.7

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

812

4318

1.93

64.24

2.5

3.2

206.1

58.9

mg/l

0.92

646

3488

(40768441) Liver Pathology biopsy report

241

732

3.33

64.10

2.0

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

794

4194

1.94

64.08

2.5

3.1

4.2

3.3

ratio

0.20

304

(3003181) Sodium [Moles/volume] in Urine

503

2235

2.29

64.04

1.8

1.3

59.9

62.9

mmol/l

0.90

393

1774

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

443

1863

2.42

63.95

1.7

1.5

111.0

115.4

u/ml

0.31

394

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

649

3201

2.07

63.54

5.8

3.8

1.9

1.6

mg/l

11.41

605

2871

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

535

2452

2.22

63.23

3.5

3.1

341.5

1061.2

u/ml

1.48

482

2236

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5316

43280

1.35

62.85

5.4

4.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

412

1705

2.46

61.61

4.2

2.9

748.5

1700.3

u/ml

0.92

116

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

591

2862

2.11

60.73

1.8

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

468

2063

2.31

60.70

2.4

1.9

1.8

1.7

mmol/l

1.51

452

2020

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

749

3975

1.93

59.55

1.6

311.4

274.7

titre

0.12

170

(3025159) Blasts/100 leukocytes in Blood

1381

8753

1.64

59.49

4.7

4.0

0.0

0.3

2.29

430

2270

(40760888) Immunoglobulin light chains.free panel - Serum

641

3234

2.03

58.95

2.5

3.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

433

1870

2.35

58.88

1.5

1.3

320.4

268.1

u/ml

2.46

268

1156

(3028707) Methadone [Presence] in Urine by Screen method

323

1221

2.68

58.26

4.1

2.8

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

100

7.93

58.19

3.4

1.8

54.4

61.7

0.61

(3048929) Epstein Barr virus Ab [Presence] in Serum

584

2865

2.08

57.97

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

446

1989

2.28

56.28

1.5

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

166

430

3.89

56.11

35.7

34.8

6.9

7.4

ug/l

1.82

143

390

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

169

445

3.83

55.81

3.1

1.7

134.8

128.1

umol/l

0.10

233

(3022313) Gas panel - Capillary blood

1030

6164

1.72

55.08

7.1

4.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

249

847

2.97

54.75

1.2

332.0

90.0

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

249

847

2.97

54.75

1.2

147.5

171.6

titre

0.23

154

(3042733) HLA Ab [Presence] in Serum

141

330

4.30

54.66

3.8

5.0

—

(3009508) Creatinine [Moles/volume] in Urine

4689

38100

1.33

53.98

3.7

3.2

7.1

7.6

mmol/l

13.90

3935

31439

(3029937) Albumin [Presence] in Urine by Test strip

3912

30968

1.36

53.53

5.5

4.2

0.0

estimate

0.09

1407

9894

(3016650) Hepatitis A virus Ab [Presence] in Serum

380

1624

2.37

52.93

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

814

4605

1.81

52.85

1.4

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

152

386

3.97

52.84

3.9

2.0

165.2

157.5

0.40

141

360

(3022806) Fractional oxyhemoglobin in Capillary blood

382

1639

2.36

52.74

2.4

1.8

88.1

89.3

2.36

372

1617

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

629

3283

1.96

52.46

1.4

13.5

16.1

iu/ml

0.15

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

222

731

3.07

51.70

2.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

397

1749

2.30

51.57

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

463

2182

2.16

51.02

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

216

706

3.09

50.95

1.1

1.0

295.5

285.4

mg/l

0.95

191

634

(3011397) Hemoglobin [Presence] in Urine by Test strip

3471

27143

1.36

50.94

4.5

3.8

—

(40768804) Tissue Pathology biopsy report

5336

44446

1.31

50.65

2.4

2.2

—

(3000494) Fungus identified in Specimen by Culture

1846

12950

1.48

50.04

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

488

2379

2.09

49.24

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1068

6657

1.65

48.81

1.2

—

(3039000) Anion gap in Blood

551

2817

1.99

48.77

10.0

6.7

11.7

11.3

mmol/l

2.07

509

2526

(3018572) Chloride [Moles/volume] in Blood

551

2818

1.99

48.72

10.0

6.7

104.8

105.0

mmol/l

0.38

509

2527

(3024891) Influenza virus A+B Ag [Presence] in Specimen

562

2913

1.96

47.81

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

407

1874

2.20

47.55

3.4

3.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

7.93

47.17

3.6

1.7

16.9

17.7

0.05

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

370

1661

2.26

45.99

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1384

9326

1.53

45.26

3.8

2.7

59.1

62.4

ml/min/173m2

2.31

656

3870

(3003694) ABO and Rh group [Type] in Blood

3704

29715

1.33

44.77

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3695

29635

1.33

44.74

4.9

3.5

—

(3051651) Icteric interference index of Serum or Plasma

213

745

2.89

44.62

4.7

3.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

447

2195

2.07

44.24

3.6

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4644

38529

1.30

43.66

4.4

4.0

17.6

9.5

mg/mmol

13.31

3205

24678

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1481

10208

1.50

43.42

6.3

3.8

1.2

mmol/l

5.13

1349

8817

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

5068

1.70

43.38

2.1

2.2

3.9

3.8

g/l

0.57

601

3556

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

842

5084

1.69

43.36

2.1

2.2

7.5

7.4

g/l

0.89

612

3691

(4035726)

1443

9906

1.50

43.13

1.5

1.4

—

(4198724)

128

333

3.87

43.10

4.0

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

5079

1.69

43.02

2.1

2.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

377

1755

2.18

42.88

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1073

6916

1.59

42.62

3.5

2.9

0.4

0.3

e6/l

1.00

1055

6774

(44790049)

303

1291

2.37

42.55

1.6

1.5

—

(44806118)

303

1291

2.37

42.55

1.6

1.5

—

(44790048)

303

1291

2.37

42.55

1.6

1.5

—

(44790047)

303

1291

2.37

42.55

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

794

4752

1.71

42.23

2.1

2.2

10.4

10.3

g/l

0.20

670

3905

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

365

1689

2.19

42.15

2.3

2.1

31.3

32.9

7.33

360

1675

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

549

2970

1.88

41.06

1.6

1.5

0.2

g/l

0.15

513

2795

(3019150) Specific gravity of Urine by Refractometry

3172

25146

1.33

41.06

5.3

4.3

1.0

kg/l

0.48

500

3863

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

767

4582

1.71

41.06

2.7

—

(3024932) HLA-DR beta [Type]

125

333

3.78

40.71

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

303

1317

2.33

40.67

4.5

3.3

—

(3024471) HLA-A [Type]

127

343

3.72

40.56

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

555

3038

1.86

40.01

5.1

3.4

1.7

mmol/l

0.48

544

2968

(3019550) Sodium [Moles/volume] in Serum or Plasma

12443

117326

1.35

39.90

37.3

18.6

139.0

139.6

mmol/l

109.39

12233

114035

(3024980) IgG subclass 4 [Mass/volume] in Serum

348

1616

2.18

39.85

1.6

0.8

0.9

g/l

0.70

265

1222

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

559

3076

1.85

39.63

1.6

1.5

1.2

g/l

0.54

527

2897

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

323

1460

2.24

39.53

1.7

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

212

4.50

39.23

3.5

2.8

14.0

14.7

ml/dl

1.53

198

(3012516) Albumin [Mass/volume] in Urine

4379

36445

1.28

39.15

3.6

3.2

542.5

379.5

mg/l

1.36

3091

23598

(3004809) Band form neutrophils/100 leukocytes in Blood

416

2095

2.01

38.44

3.3

3.6

1.6

1.5

0.27

308

1598

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9107

82696

1.26

38.21

4.3

3.8

14.9

pmol/l

0.04

8157

73837

(3023103) Potassium [Moles/volume] in Serum or Plasma

12451

117594

1.34

38.07

37.4

18.8

4.0

mmol/l

0.72

12215

114096

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

316

1440

2.22

37.93

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

774

4734

1.67

37.89

2.2

3.2

3.1

g/l

3.00

611

3620

(40761535) Cells panel - Urine sediment

1473

10409

1.46

37.83

4.2

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

560

3133

1.82

37.62

1.6

4.5

7.0

iu/ml

0.25

146

748

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

383

1889

2.05

37.49

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

420

2142

1.99

37.45

1.5

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

104

258

4.05

37.44

1.3

1.2

100.4

100.1

0.02

238

(3024522) Salmonella sp identified in Specimen by Organism specific culture

313

1431

2.21

37.28

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

311

1421

2.21

37.10

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

310

1420

2.21

36.75

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

310

1423

2.20

36.56

1.7

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

102

254

4.04

36.55

2.6

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

309

1419

2.20

36.41

1.7

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

388

1954

2.01

35.87

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

521

2894

1.83

35.83

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

9921

91273

1.25

35.72

40.1

18.9

14.5

13.8

274.36

9760

89104

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

268

1171

2.31

35.59

1.2

62.2

66.5

u/l

0.35

210

761

(4281824)

236

977

2.44

35.40

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7018

62227

1.24

35.11

3.1

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

323

1533

2.13

35.03

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

182

668

2.74

34.93

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

632

3746

1.72

34.77

2.1

2.2

0.1

0.0

g/l

0.85

568

3374

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

837

5335

1.60

34.70

8.0

4.2

24.4

24.8

mmol/l

3.65

771

4863

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

341

1661

2.08

34.55

1.5

1.4

—

(3013512) EKG study

4243

35599

1.27

34.54

5.4

4.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

282

1276

2.23

34.48

3.9

3.3

6.9

12.9

nmol/l

0.72

270

1246

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

597

3493

1.74

34.41

2.2

0.0

g/l

0.11

534

3136

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

589

3434

1.74

34.38

2.2

2.3

0.0

g/l

0.00

532

3127

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

702

4302

1.66

34.08

2.2

2.3

1.0

1.1

g/l

0.25

593

3593

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

171

619

2.78

33.72

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

511

2875

1.80

33.70

1.4

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

184

4.47

33.68

1.6

1.2

106.0

104.4

0.12

174

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

654

3948

1.69

33.63

2.1

35.5

37.2

g/l

8.50

561

3303

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

171

621

2.77

33.51

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

477

2635

1.84

33.41

3.7

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

540

3107

1.77

33.01

1.8

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

261

3.81

32.81

1.2

1.1

82.2

84.6

0.32

136

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

383

1989

1.95

32.45

5.0

3.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

361

1837

1.99

32.44

1.6

1.5

5164.3

2360.9

e6/l

0.55

279

1311

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

255

3.82

32.29

1.2

78.0

83.5

0.61

137

(3027456) Digoxin [Moles/volume] in Serum or Plasma

529

3055

1.76

31.93

3.4

3.1

0.8

nmol/l

0.09

407

2361

(3037121) Protein [Mass/volume] in Urine

687

4262

1.64

31.78

3.4

3.1

0.4

0.3

g/l

0.79

359

1842

(3000764) Benzodiazepines [Presence] in Urine

497

2823

1.79

31.76

3.6

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

391

2068

1.91

31.38

1.6

1.5

28.5

32.3

g/l

6.94

345

1833

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

174

660

2.65

31.37

1.2

105.6

95.8

u/l

0.59

159

558

(3028300) Cannabinoids [Presence] in Urine

499

2850

1.78

31.30

3.6

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

1725

2.00

31.17

1.4

—

(3044889) 12 lead EKG panel

8771

80179

1.22

30.89

5.1

4.1

—

(3027008) Opiates [Presence] in Urine

496

2844

1.77

30.70

3.2

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

348

1783

1.97

30.68

3.5

2.4

—

(3019977) pH of Arterial blood

191

767

2.51

30.65

2.5

2.4

7.4

0.06

284

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

270

3.65

30.51

3.7

3.5

7.6

7.7

mg/l

0.03

216

(3000093) Morphology [Interpretation] in Blood Narrative

268

1253

2.16

30.26

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

502

2903

1.75

30.17

5.3

3.5

7.9

7.7

mmol/l

0.72

491

2843

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

183

4.22

29.43

1.3

1.2

72.8

70.3

0.18

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

836

5535

1.54

29.30

2.3

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

327

1670

1.98

29.12

1.6

1.5

74631.4

60414.9

e6/l

0.37

214

978

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

215

933

2.32

29.10

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

182

4.19

28.77

1.3

1.2

82.6

77.0

0.55

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

775

5066

1.56

28.77

2.2

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

286

1407

2.05

28.28

1.3

1.2

4.7

u/ml

0.01

124

458

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

202

866

2.35

28.13

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

479

2789

1.74

28.12

3.7

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

661

4186

1.61

28.11

1.2

1.1

135.7

240.9

titre

—

(3040151) Glucose [Moles/volume] in Capillary blood

308

1563

1.99

27.95

8.4

12.3

7.7

7.4

mmol/l

0.80

253

1295

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

198

845

2.36

27.86

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

164

643

2.57

27.71

1.2

34.7

27.6

u/l

0.69

148

533

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

271

1321

2.07

27.49

1.2

1.1

113.4

115.2

0.32

248

1177

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

342

1820

1.90

26.99

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

1338

9848

1.39

26.99

5.6

4.1

—

(4306422)

275

1363

2.04

26.67

1.2

—

(3016038) Potassium [Moles/volume] in Urine

191

819

2.35

26.61

1.6

1.1

32.7

35.7

mmol/l

1.01

160

682

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

216

977

2.23

26.54

2.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

253

3.53

26.50

3.0

2.8

148.3

155.8

au/ml

0.05

(3017315) Amylase [Enzymatic activity/volume] in Urine

152

590

2.59

26.25

1.3

1.2

249.6

415.2

u/l

1.19

140

552

(3042517) Benzodiazepines panel - Urine

6.34

26.00

3.8

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

157

623

2.54

25.91

2.0

1.9

—

(3008295) Osmolality of Serum or Plasma

244

1170

2.10

25.88

1.5

1.4

276.1

278.8

mosm/kgh2o

0.77

182

869

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

258

1267

2.05

25.68

3.0

2.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10782

101408

1.22

25.58

5.2

4.5

2.0

2.2

mu/l

2.04

9784

91243

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

381

2.98

25.49

1.9

1.5

2863224.3

1655817.4

iu/ml

—

(3052592) Norovirus Ag [Presence] in Stool

275

3.36

25.37

1.5

1.3

—

(3045716) Anion gap in Serum or Plasma

143

548

2.62

25.36

2.3

2.2

9.7

8.9

mmol/l

1.41

113

407

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

257

1267

2.05

25.32

1.8

1.7

—

(3045788) Cell count panel - Pleural fluid

277

1404

1.99

25.26

1.7

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

241

1177

2.06

24.37

1.8

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

271

1384

1.98

24.21

1.4

1.3

606.4

460.5

u/l

0.30

254

1308

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

271

1384

1.98

24.21

1.3

1.2

3.7

4.2

u/ml

0.37

135

608

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

270

1380

1.97

24.07

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

449

7283

0.60

24.03

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

164

692

2.38

23.75

1.7

1.5

7.4

6.0

u/l

0.37

325

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

220

1057

2.10

23.26

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

355

2013

1.78

22.90

1.2

1.3

42.1

37.3

u/l

0.29

315

1734

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

380

2199

1.75

22.86

2.7

2.3

4141.0

5306.3

u/l

0.36

108

836

(3023419) Bacteria identified in Sputum by Culture

294

1574

1.88

22.85

2.5

2.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

153

4.06

22.63

1.5

1.7

60.4

45.4

pmol/l

0.54

125

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

459

7289

0.62

22.45

1.7

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

394

2.80

22.29

2.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

394

2.80

22.29

2.4

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

369

2133

1.75

22.29

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

184

842

2.20

22.06

1.1

—

(3000012) Reticulocyte production index

173

774

2.25

21.92

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

376

2197

1.73

21.87

2.2

1.7

0.9

0.8

nmol/l

0.80

313

1814

(3017817) Protein [Mass] in Urine collected for unspecified duration

234

1178

2.00

21.82

2.1

2.3

—

0.4

—

(40768806) Pleura Pathology biopsy report

294

1599

1.85

21.77

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

211

1025

2.07

21.70

1.4

1.3

0.4

g/l

0.11

147

716

(3028192) IgG subclass 2 [Mass/volume] in Serum

211

1026

2.07

21.65

1.4

1.3

3.0

2.9

g/l

0.06

144

720

(3027135) IgG subclass 1 [Mass/volume] in Serum

211

1026

2.07

21.65

1.4

1.3

7.1

6.9

g/l

0.16

146

713

(4062490)

210

1027

2.06

21.23

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

212

1046

2.04

20.93

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

212

1046

2.04

20.93

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

212

1046

2.04

20.93

1.6

1.7

—

(3004451) EKG impression Narrative

151

651

2.33

20.89

1.4

1.3

—

(3017569) Oxygen content in Arterial blood

144

610

2.37

20.74

2.2

2.1

—

(3012441) Differential panel - Pleural fluid

290

1598

1.83

20.62

1.7

1.5

—

(3049717) Cytology report of Urine Cyto stain

802

5655

1.44

20.53

2.7

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

10615

100399

1.19

20.51

34.8

16.8

36.9

39.4

98.75

6710

67118

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

5.79

20.50

1.2

2092.8

1324.3

u/l

0.17

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

200

974

2.07

20.46

1.3

1.2

1.5

1.4

nmol/l

0.37

180

873

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

150

656

2.30

20.10

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

1033

7647

1.38

19.97

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

393

2.68

19.62

2.1

1.9

18723.4

36371.0

u/ml

0.26

(40761511) CBC panel - Blood by Automated count

12118

116181

1.22

19.60

31.8

14.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

147

645

2.29

19.56

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

147

645

2.29

19.56

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

109

4.41

19.56

1.7

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

463

2.54

19.55

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

254

1367

1.87

19.49

1.9

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

339

2.81

19.45

2.5

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

253

1363

1.87

19.36

1.5

1.4

6.7

6.2

mmol/l

1.42

237

1253

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12394

119148

1.23

19.24

35.2

18.5

90.5

82.8

umol/l

38.36

12387

119085

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

201

1005

2.01

19.17

1.2

1.1

95.1

95.2

0.03

189

930

(40757494) Bilirubin.total [Moles/volume] in Blood

153

690

2.23

19.08

2.2

2.3

34.0

39.0

umol/l

0.14

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

594

2.32

18.76

3.3

3.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

140

613

2.30

18.74

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

140

613

2.30

18.74

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

118

479

2.47

18.71

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

814

5854

1.41

18.68

3.2

4.3

4.4

pmol/l

2.17

714

5132

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

260

1432

1.83

18.56

1.3

0.6

2.6

nmol/l

1.08

245

1380

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

237

1268

1.88

18.55

1.3

—

nmol/l

—

(4268621)

188

929

2.04

18.54

2.4

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

261

1440

1.83

18.53

1.3

0.4

0.3

nmol/l

0.26

108

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

242

1304

1.87

18.53

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

256

1406

1.83

18.45

4.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

215

1116

1.94

18.44

1.4

1.3

13.7

14.0

u/l

0.04

192

1032

(3035637) Corticotropin [Mass/volume] in Plasma

247

1345

1.85

18.30

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1849

15047

1.26

17.92

1.6

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

131

569

2.31

17.89

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

643

4476

1.46

17.64

1.8

39.6

38.6

u/l

0.54

550

3858

(3025315) Body weight

4.66

17.45

6.3

5.0

—

(1761868) Lipid panel - Serum or Plasma

3025

34946

0.83

17.42

3.5

3.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

171

837

2.05

17.34

3.7

2.1

21.6

8.9

umol/l

2.60

132

609

(3013727) Leukocytes other/100 leukocytes in Blood

104

417

2.50

16.97

3.3

3.9

59.6

53.0

2.40

104

396

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

249

1394

1.80

16.90

2.3

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

236

1300

1.83

16.89

3.5

3.4

63.3

58.4

2.24

142

816

(3020717) Zinc [Moles/volume] in Serum or Plasma

106

433

2.46

16.64

2.3

1.4

16.0

24.1

umol/l

3.10

415

(3005322) IgE [Units/volume] in Serum or Plasma

792

5786

1.39

16.58

1.3

344.5

260.2

u/ml

0.70

735

5324

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1908

15714

1.24

16.57

1.3

1.2

12.9

13.6

u/ml

0.15

680

5669

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.25

16.50

4.2

3.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

200

1053

1.91

16.50

1.5

1.4

15.2

13.2

u/l

2.56

189

1010

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

569

3920

1.47

16.49

1.1

1.6

1.0

u/ml

0.79

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.93

16.47

2.3

2.1

140.1

183.0

ug/g

0.82

(3035947) Staphylolysin Ab [Units/volume] in Serum

128

571

2.25

16.46

1.1

3.5

4.9

iu/ml

0.53

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10980

104800

1.18

16.43

28.1

15.0

75.9

76.7

ml/min/173m2

2.38

9665

86677

(3014148) Varicella zoster virus Ab [Titer] in Serum

204

1092

1.88

16.01

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

599

2.20

15.88

1.2

—

(3002256) Pathology report gross observation

1815

14934

1.24

15.85

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

261

1513

1.74

15.75

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

859

6416

1.36

15.68

5.4

3.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2020

16835

1.23

15.65

1.3

36.1

36.5

iu/ml

0.04

609

5108

(4010399)

1051

8092

1.32

15.62

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.62

15.58

5.1

2.9

—

(3019225) pH of Specimen

1523

12313

1.26

15.50

5.7

4.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

294

4750

0.61

15.49

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

606

2.17

15.45

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

154

3.45

15.43

1.9

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

476

3210

1.50

15.37

2.3

2.4

198.7

119.9

ug/min

1.98

278

1906

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

118

3.82

15.22

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

269

1588

1.71

15.22

4.6

4.5

354.1

348.6

umol/l

0.25

235

1334

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

218

1212

1.81

15.19

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

484

3296

1.48

14.91

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12332

119127

1.19

14.87

17.4

10.5

26.5

26.0

u/l

1.03

11991

114059

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

854

1.95

14.72

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

100

424

2.37

14.52

1.9

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

181

3.16

14.43

2.2

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

529

3690

1.45

14.41

1.3

1.2

0.5

1.0

u/ml

1.26

365

(3023511) Choriogonadotropin [Units/volume] in Urine

190

1035

1.85

14.18

1.7

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

536

2.19

14.18

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

524

2.20

14.12

1.1

ratio

0.10

175

(3035880) pH of Pleural fluid

159

818

1.95

14.12

1.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

304

1894

1.62

14.00

2.5

2.6

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

5.10

13.59

1.0

1.1

34.1

22.1

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

5.10

13.59

1.0

1.1

42.0

27.8

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

222

1287

1.74

13.47

3.6

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

516

3630

1.44

13.45

6.6

4.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

369

2428

1.53

13.44

1.1

4.3

4.7

u/ml

0.09

215

(3001186) Copper [Moles/volume] in Serum or Plasma

211

2.90

13.36

1.3

1.2

16.7

16.8

umol/l

0.02

188

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

111

3.70

13.29

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

201

1137

1.78

13.28

1.8

1.9

0.3

1.1

g/24h

3.63

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

437

2992

1.47

13.15

2.1

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

321

2.50

13.14

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

105

476

2.21

13.09

8.5

6.5

24.0

24.8

mmol/l

0.86

427

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

162

3.15

12.95

2.3

2.6

65.3

69.5

mg/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

327

2.45

12.65

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

191

1085

1.77

12.48

1.5

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

153

813

1.89

12.40

2.9

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

415

2847

1.47

12.38

1.8

1.9

12.1

11.6

mg/l

0.31

385

2633

(3022621) pH of Urine by Test strip

986

7780

1.29

12.20

3.7

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

280

2.54

12.13

2.2

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

349

2.36

11.90

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

181

1029

1.77

11.82

1.4

—

(3011412) CD3 cells [#/volume] in Blood

178

1008

1.77

11.78

2.3

2.4

1.0

1.1

e9/l

1.28

105

618

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.14

11.75

1.8

1.1

64.9

40.9

mg/l

—

(3044927) Protein electrophoresis panel - Urine

222

1339

1.67

11.71

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1000

7947

1.28

11.69

2.3

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

139

737

1.89

11.39

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

738

1.89

11.34

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

911

7189

1.28

11.27

2.2

2.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

262

2.53

11.16

3.2

2.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

228

2.64

11.08

1.6

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

415

2919

1.43

10.91

1.8

1.6

19690.2

14896.1

e6/l

0.89

296

2088

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

114

574

1.99

10.89

1.2

1.1

45.5

29.4

u/l

0.58

430

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

169

2.90

10.86

1.6

1.3

70.6

74.7

0.41

139

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

272

2.47

10.82

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

197

2.75

10.80

1.6

110.1

111.8

ug/l

0.04

169

(3021788) Differential panel - Synovial fluid

324

2182

1.50

10.67

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

263

2.48

10.58

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

253

2.50

10.42

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

113

577

1.97

10.39

1.2

1.1

103.4

93.1

u/l

0.33

448

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

142

3.03

10.30

4.3

5.5

65.1

51.9

ug/min

0.48

119

(21494434) Karyotype in Bone marrow

182

1082

1.69

10.20

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

350

2.23

10.08

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

163

947

1.73

9.95

1.4

19.3

26.3

u/l

2.94

133

777

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

114

3.25

9.95

4.5

3.0

1.7

1.2

mg/l

0.40

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

780

1.80

9.87

1.4

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

216

1354

1.60

9.85

1.9

2.1

3.7

2.7

titre

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

180

2.73

9.71

1.4

1.3

999.6

244.6

u/l

0.43

131

(3041672) Baker's yeast Ab [Presence] in Serum

4.59

9.51

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

188

1151

1.64

9.46

1.6

1.5

23.2

27.8

1.25

128

716

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.45

9.43

1.3

0.9

ml/s/173m2

0.65

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

117

626

1.88

9.41

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

117

626

1.88

9.41

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

117

626

1.88

9.41

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

117

626

1.88

9.41

1.8

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

154

898

1.72

9.31

1.7

—

(3002619) Bacteria identified in Specimen by Culture

255

2.40

9.31

1.6

1.2

—

(3000492) Spirometry study

1174

9748

1.22

9.28

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

402

2.10

9.28

1.2

1.4

—

(3004775) Volume in Urine collected for unspecified duration

177

1073

1.66

9.26

2.1

2.2

768.6

662.1

1.53

112

702

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

274

1840

1.50

9.22

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

233

1515

1.55

9.12

1.6

1.5

63.0

62.0

0.14

155

945

(3034426) Prothrombin time (PT)

333

2.20

9.11

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

340

2.18

9.07

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

187

2.62

9.05

1.5

1.2

1.5

1.4

mmol/l

0.06

121

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

176

2.68

9.01

6.4

5.4

—

(3045142) Bone marrow Pathology biopsy report

214

1369

1.57

9.00

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

316

2.22

8.97

12.5

7.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

186

1152

1.62

8.96

1.5

1.3

154497.3

154967.0

e6/l

0.00

137

783

(3032773) Endomysium IgG Ab [Titer] in Serum

135

767

1.77

8.96

1.1

—

titre

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

342

2.17

8.95

4.5

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

157

931

1.69

8.95

1.6

1.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

102

532

1.92

8.89

1.7

2.3

2065.3

1280.2

u/ml

0.89

526

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10738

103749

1.12

8.86

7.4

6.2

41.5

40.5

mmol/mol

16.98

9872

94699

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

143

831

1.73

8.78

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

123

687

1.80

8.66

3.5

3.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

622

4841

1.30

8.63

1.1

—

(3028433) Virus identified in Specimen by Culture

387

2.07

8.62

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

354

2.12

8.62

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

748

1.76

8.57

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

147

2.79

8.55

1.4

1.3

9.2

212808.2

nmol/l

0.72

125

(3023383) Lactate [Moles/volume] in Pleural fluid

463

1.97

8.54

1.5

1.3

2.9

3.6

mmol/l

1.69

423

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

249

1667

1.50

8.54

1.2

1.1

—

(3017704) Immunofixation for Urine

127

720

1.77

8.52

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

132

758

1.75

8.47

2.0

1.6

55.8

72.7

umol/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

124

700

1.78

8.44

2.5

490.3

512.8

e6/l

0.19

104

582

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

206

2.48

8.42

2.3

1.7

102.0

117.3

au/ml

—

(44786800) Granulocytes/100 leukocytes in Body fluid

195

2.52

8.34

1.4

1.3

27.0

24.0

0.20

151

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

433

1.99

8.33

1.3

337.2

213.3

ug/l

0.18

233

(3010503) CD19 cells [#/volume] in Blood

116

645

1.80

8.31

2.6

2.5

0.2

0.4

e9/l

1.10

111

619

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

307

2.19

8.31

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

269

2.27

8.29

13.2

7.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

165

1013

1.64

8.27

1.3

1.4

32.8

23.1

iu/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

135

2249

0.60

8.26

1.5

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

120

676

1.78

8.24

2.5

2.6

0.2

e9/l

0.54

106

582

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.81

8.22

4.2

3.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

358

2586

1.39

8.20

1.4

514.6

553.9

mg/l

0.46

330

2449

(3044941) Cell count panel - Synovial fluid

272

1870

1.46

8.19

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

236

1581

1.50

8.09

1.1

5436.3

7068.5

iu/ml

0.08

339

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

321

2281

1.42

8.09

1.4

1.3

3.9

3.8

mmol/l

0.53

292

2135

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

320

2273

1.42

8.09

1.5

1.4

32.5

23.4

e6/l

0.17

244

1749

(3003338) MCHC [Mass/volume]

9658

92952

1.11

8.08

43.3

20.2

330.0

332.3

g/l

97.51

9553

91955

(3028717) Thiamine [Mass/volume] in Blood

103

3.11

8.07

1.1

—

(3012565) Volume of 24 hour Urine

106

579

1.84

8.06

2.5

2.3

1733.0

1924.3

1.12

490

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

320

2276

1.41

8.03

1.5

1521.1

3789.1

e6/l

0.62

263

1847

(3044290) Cell count panel - Cerebral spinal fluid

297

2089

1.43

7.93

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

164

1019

1.62

7.86

1.4

1.6

27.0

26.3

u/ml

0.06

227

(3016750) Collection duration of Urine

129

754

1.72

7.82

2.1

512.0

497.7

min

1.06

540

(1175426) CD3 cells/100 lymphocytes in Blood

135

800

1.69

7.78

1.8

2.1

71.3

70.6

0.18

130

760

(3009214) Lutropin [Units/volume] in Serum or Plasma

355

2587

1.38

7.74

1.4

11.1

9.2

u/l

1.87

306

2063

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.17

7.71

1.1

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

265

2.23

7.71

3.5

1.9

8.6

9.4

mg/l

0.54

215

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

194

1260

1.55

7.71

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.42

7.64

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

584

1.80

7.56

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

132

784

1.69

7.56

1.8

2.0

12.4

14.7

0.87

351

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

316

2268

1.40

7.55

1.7

3.6

4.4

iu/l

1.29

100

734

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

435

1.94

7.55

1.1

2.0

16.9

u/ml

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

109

615

1.78

7.49

1.4

1.3

1.1

nmol/l

0.55

467

(3016244) Insulin [Units/volume] in Serum or Plasma

493

1.87

7.47

3.1

3.0

27.6

26.4

mu/l

0.11

459

(3006270) Folate [Moles/volume] in Blood

176

1129

1.57

7.41

1.2

333.6

343.1

nmol/l

0.23

134

901

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

125

2.80

7.39

1.7

2.1

1.2

1.4

mmol/l

0.21

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

390

1.98

7.39

1.0

1.1

91.2

97.5

1.06

301

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

100

553

1.81

7.35

1.5

1.4

61.9

63.5

0.17

454

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

151

936

1.62

7.34

1.9

1.7

5.3

4.4

mg/l

0.97

140

884

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

524

4077

1.30

7.34

3.2

3.6

53.6

79.1

u/ml

1.64

506

3894

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

142

867

1.64

7.33

1.2

1.3

45.0

501.7

titre

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

2213

1.40

7.33

1.3

198.2

224.2

miu/ml

0.46

914

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

285

2031

1.41

7.13

1.2

3.1

4.8

u/ml

0.32

157

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

257

1799

1.44

7.10

1.7

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

329

2.04

7.02

1.2

—

(3013466) aPTT in Blood by Coagulation assay

4.19

6.99

1.1

1.2

38.1

40.1

0.38

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.36

6.94

1.1

1.2

2.9

0.9

u/field

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

2.59

6.91

2.2

2.0

17.2

16.9

umol/l

0.04

147

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

127

767

1.66

6.87

2.6

2.5

690.2

605.8

e6/l

0.55

293

(3008536) Aspergillus sp Ab [Presence] in Serum

221

2.27

6.83

2.3

2.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

360

1.98

6.82

1.7

1.3

22.4

21.8

0.07

295

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

347

2578

1.35

6.76

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

474

1.84

6.75

1.5

1.4

2.4

2.9

0.26

401

(3041918) Cholesterol [Moles/volume] in Pleural fluid

261

2.15

6.74

1.4

1.2

1.3

1.5

mmol/l

0.79

164

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

335

2.00

6.70

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.00

6.69

1.2

1.1

—

mmol/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

288

2088

1.39

6.55

1.2

—

15.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2689

29503

0.89

6.55

3.0

3.2

0.8

ug/l

0.09

1844

20471

(3017732) Neutrophils [#/volume] in Blood

910

7634

1.20

6.52

3.5

3.0

4.3

4.2

e9/l

0.63

650

5627

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

1093

1.53

6.49

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

326

2419

1.36

6.43

1.3

1.2

12.5

6.0

u/ml

0.47

249

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.29

6.39

1.0

1.1

u/field

0.01

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

329

2449

1.35

6.36

1.3

7.4

7.5

u/ml

0.02

380

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

251

1788

1.41

6.34

1.8

1.9

19.5

23.9

ug/l

0.63

243

1743

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

308

2.02

6.34

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

112

670

1.68

6.32

2.5

2.4

—

(3014271) Vancomycin [Susceptibility]

136

861

1.58

6.14

3.4

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

345

2610

1.33

6.01

1.2

21.1

42.9

u/ml

1.36

140

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.34

5.98

12.9

10.3

198.8

189.3

e6/l

0.03

(3007463) Buprenorphine [Presence] in Urine

4.52

5.97

3.3

8.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

167

1118

1.50

5.88

1.1

1.0

4.2

2.8

u/ml

0.42

459

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

210

2.19

5.87

3.3

4.5

38.7

74.8

u/l

0.96

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.19

5.85

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

161

2.36

5.77

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

161

2.36

5.77

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

161

2.36

5.77

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

348

2654

1.32

5.75

1.8

1.7

355.5

300.2

mu/l

1.19

318

2420

(40757373) Influenza virus identified in Isolate

259

2.05

5.70

1.5

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

109

2.66

5.64

1.2

1.1

75.2

79.0

ug/l

0.18

(3036670) Protein [Mass/volume] in Synovial fluid

393

1.84

5.63

1.2

34.0

40.7

g/l

1.96

208

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

533

1.71

5.61

1.2

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

176

2.28

5.59

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

474

1.75

5.59

1.8

1.5

14.1

8.6

ug/l

0.81

427

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1715

15311

1.14

5.55

13.4

7.8

—

(3014891) Appearance of Pleural fluid

236

2.08

5.49

1.6

—

(3045414) Leukocytes [Presence] in Urine

613

5040

1.23

5.45

2.2

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.23

5.43

1.4

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

496

3988

1.25

5.42

2.1

2.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

600

1.65

5.39

2.3

2.6

212.4

207.8

u/l

0.22

595

(3039162) Centromere protein B Ab [Units/volume] in Serum

168

1150

1.47

5.34

1.2

60.9

53.3

u/ml

—

(3011985) Renin [Units/volume] in Plasma

203

1440

1.41

5.33

1.2

1.4

50.4

68.8

mu/l

0.70

172

1271

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

579

1.66

5.33

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.54

5.31

1.6

1.4

149.4

104.6

ug/l

0.30

(21494815) CD4 cells/100 lymphocytes in Specimen

139

918

1.52

5.27

2.1

2.2

33.8

40.4

0.61

109

(3013336) Amino acids [Identifier] in Serum or Plasma

4.62

5.25

2.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

304

1.91

5.17

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

305

1.90

5.12

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

231

2.04

5.03

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.17

5.02

1.6

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

386

1.79

5.02

2.7

2.2

13.3

11.9

0.23

353

(3000919) Neutrophils/100 leukocytes in Pleural fluid

423

1.75

5.01

1.4

23.4

20.5

0.39

384

(3001019) Free T4 and TSH panel - Serum or Plasma

271

3569

0.75

4.99

1.7

1.6

—

(3036603) Volume of Urine

119

770

1.55

4.98

1.7

1.6

1684.1

1975.2

1.87

202

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

100

623

1.61

4.92

2.6

39.8

36.5

0.56

206

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

245

1821

1.35

4.89

1.2

32.6

42.3

u/ml

0.58

180

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

4.87

1.1

1.5

—

(3007461) Platelets [#/volume] in Blood

12626

124112

1.11

4.83

48.0

22.8

242.9

242.3

e9/l

0.36

12391

120235

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.58

4.77

1.2

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

123

810

1.52

4.77

2.4

2.2

17.3

17.9

nmol/l

0.29

114

762

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

271

1.92

4.74

1.9

2.4

7.4

7.9

mmol/l

0.56

166

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.94

4.70

2.7

3.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

395

1.75

4.68

2.5

2.7

28.8

28.2

umol/l

0.17

288

(3016018) Differential panel - Cerebral spinal fluid

156

1083

1.44

4.67

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

308

1.85

4.67

3.3

3.1

—

(3035941) MCH [Entitic mass]

12627

124165

1.10

4.66

47.7

22.7

30.2

30.4

19.04

12462

121843

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

479

1.67

4.62

1.2

1.3

45.0

63.3

—

(3024731) MCV [Entitic volume]

12627

124175

1.10

4.62

47.8

22.8

91.4

91.3

1.51

12465

121857

(3014051) Protein [Presence] in Urine by Test strip

333

2607

1.28

4.61

2.7

2.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

219

2.01

4.58

1.6

1.5

6.4

9.8

0.61

115

(3026361) Erythrocytes [#/volume] in Blood

12627

124186

1.10

4.58

47.9

22.8

4.2

4.5

e12/l

307.65

12342

119861

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

687

5814

1.19

4.57

1.2

112.8

138.7

iu/ml

0.94

224

2060

(3000963) Hemoglobin [Mass/volume] in Blood

12629

124210

1.10

4.57

48.5

23.0

125.5

134.9

g/l

307.65

12460

121903

(3020491) Glucose [Moles/volume] in Blood

129

870

1.49

4.49

2.0

7.1

7.0

mmol/l

0.11

101

593

(3010813) Leukocytes [#/volume] in Blood

12627

124215

1.10

4.47

48.0

22.9

7.3

6.9

e9/l

40.40

12352

119889

(3013166) Neutrophils/100 leukocytes in Synovial fluid

386

1.74

4.46

1.7

1.3

63.9

58.7

0.60

326

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

108

703

1.54

4.45

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

271

1.88

4.42

2.2

816.5

793.9

e6/l

0.01

150

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

257

1.91

4.41

1.1

1.2

204.9

259.8

pmol/l

0.99

184

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

396

3184

1.25

4.41

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

107

697

1.54

4.40

1.4

2.0

2.5

2.9

u/field

0.21

487

(21491868) Cryoglobulin [Mass/volume] in Serum

389

1.73

4.35

1.3

1.2

1.8

0.3

g/l

—

(3026480) Teichoate Ab [Titer] in Serum

113

2.39

4.29

1.1

—

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

162

1154

1.41

4.25

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

107

703

1.53

4.24

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

173

1247

1.39

4.24

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

704

1.52

4.22

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.90

4.16

4.9

4.8

—

(3029075) Extractable nuclear Ab panel - Serum

277

1.84

4.15

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

418

1.68

4.13

1.8

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

107

708

1.51

4.12

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

107

708

1.51

4.12

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

162

1162

1.40

4.10

3.3

3.1

49.3

51.8

mg/l

0.06

119

864

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

352

1.74

4.07

1.3

1.4

17.4

15.9

pmol/l

0.27

291

(3048879) Bone marrow aspiration report

397

1.69

4.07

1.9

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

107

710

1.51

4.07

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

172

1249

1.38

4.05

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

155

2.13

4.04

3.1

3.4

46.3

40.7

umol/l

0.81

125

(4212803)

123

2.28

4.02

1.1

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.81

3.94

6.4

4.0

19.8

12.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

394

1.68

3.92

1.1

1600.2

1516.9

miu/ml

0.24

394

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

502

1.60

3.91

2.2

2.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

121

831

1.46

3.90

1.2

11.0

11.9

mmol/l

0.61

231

(3012898) Urea [Moles/volume] in Urine

112

2.32

3.90

1.2

1.4

129.2

158.4

mmol/l

0.65

(3036180) Methadone [Presence] in Urine

7.28

3.85

9.0

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

335

2688

1.25

3.85

1.4

25.4

27.1

iu/l

0.43

288

2246

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

351

1.71

3.84

1.8

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

105

704

1.49

3.83

11.7

11.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

112

761

1.47

3.82

1.2

1.1

—

25.7

—

(40768800) Prostate Pathology biopsy report

260

3309

0.78

3.78

1.2

—

(3008898) HLA-B27 [Presence]

342

2758

1.25

3.77

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

140

2.14

3.75

2.1

2.7

66.5

69.0

pmol/l

0.05

128

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

251

1.83

3.73

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

181

1347

1.35

3.69

1.2

1.3

327.4

308.1

pmol/l

0.15

133

1010

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.00

3.68

27.1

9.2

—

(3024263) Appearance of Synovial fluid

640

1.50

3.62

1.6

1.7

—

(3047189) Immunofixation for 24 hour Urine

632

1.51

3.62

1.3

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

497

1.57

3.60

2.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

497

1.57

3.60

2.2

2.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

118

821

1.44

3.59

1.4

1.3

2.2

mmol/l

0.28

104

764

(3002621) Streptococcal DNAse B [Units/volume] in Serum

104

2.31

3.58

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

451

1.60

3.58

1.8

1.6

3.9

5.0

nmol/l

0.33

377

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

2.16

3.56

1.6

1.8

53.2

44.4

umol/l

0.61

130

(3021374) Sirolimus [Mass/volume] in Blood

7.78

3.55

16.1

6.9

7.8

6.8

ug/l

—

(3004616) Nuclear Ab [Presence] in Serum

169

1253

1.35

3.55

1.3

—

(3023410) Appearance of Cerebral spinal fluid

140

1007

1.39

3.54

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

116

807

1.44

3.54

1.4

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

3.55

3.47

2.8

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.89

3.45

2.2

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

152

2.04

3.44

1.1

1.2

17.0

18.9

u/l

0.31

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

139

2.09

3.41

1.7

2.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

100

2.30

3.41

1.3

14.4

14.8

nmol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

134

2.09

3.32

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

137

996

1.38

3.29

1.1

—

69.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

2.09

3.22

1.3

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

584

1.49

3.22

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

674

1.46

3.21

2.1

2.2

119.4

141.2

ug/min

0.14

161

(3007919) Fasciola sp Ab [Titer] in Serum

5.33

3.18

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

151

1125

1.35

3.12

2.0

2.2

2.0

u/field

0.07

433

(3045683) HLA typing for celiac disease panel - Blood or Tissue

478

1.53

3.05

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

329

1.64

3.05

2.4

2.3

134.8

146.4

nmol/l

0.28

280

(44806071)

119

2.10

3.03

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

336

2776

1.21

3.02

4.1

3.6

31.1

29.8

mg/l

0.25

244

1822

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

5.83

3.02

1.7

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

292

1.68

3.01

1.1

1.2

114.2

112.6

0.19

255

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

488

1.52

3.00

3.4

2.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

130

954

1.37

2.98

1.3

1.5

0.3

nmol/l

0.29

101

738

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

249

3087

0.80

2.98

1.5

1.7

6.2

3.8

mg/l

0.59

194

2194

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

324

1.64

2.96

1.2

25.8

22.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

588

1.46

2.94

1.6

1.5

2.3

3.2

0.41

135

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

128

2.03

2.90

1.7

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.43

2.87

1.2

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

6.67

2.86

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

259

1.70

2.85

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

487

1.50

2.83

3.2

2.2

59.5

55.7

umol/l

0.46

395

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

205

1618

1.27

2.82

2.3

2.1

21.9

27.3

mg/l

1.11

418

(3050794) Legionella sp Ab [Presence] in Serum

2.19

2.82

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.06

2.80

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

314

1.63

2.79

1.1

1.2

0.3

g/l

0.16

245

(37021550) Renin [Units/volume] in Plasma --upright

238

1.72

2.79

1.1

1.3

106.2

64.2

mu/l

0.62

173

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.40

2.79

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

276

1.67

2.78

1.6

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

144

1.95

2.78

1.3

110.6

111.7

ug/l

0.01

(3011335) Digoxin [Mass/volume] in Serum or Plasma

131

1.99

2.74

2.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

270

1.67

2.73

1.3

1.5

10.7

9.2

ug/l

0.85

270

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.75

2.67

5.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

768

6849

1.13

2.65

2.4

37.2

23.1

au/ml

0.92

306

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

151

1157

1.31

2.64

1.5

1.8

2114.3

1487.7

titre

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

237

1.69

2.56

1.8

1.5

131.1

126.0

ng/l

0.07

237

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

283

1.63

2.56

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

698

6204

1.13

2.55

1.3

57.3

53.0

au/ml

0.14

266

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

307

1.60

2.54

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

624

1.41

2.53

1.0

1.1

4.2

9.3

nmol/l

0.90

129

(3047007) Chlamydophila sp Ab [Presence] in Serum

163

1270

1.29

2.53

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.03

2.52

1.1

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

167

1306

1.28

2.52

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

300

1.60

2.51

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

306

2560

1.20

2.49

1.4

1.3

—

(40768443) Skin Pathology biopsy report

589

5189

1.14

2.48

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

166

1.81

2.43

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

431

1.49

2.42

2.2

2.0

29.3

295.1

ug/l

1.03

402

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3970

41341

0.95

2.38

4.4

4.5

21.8

22.2

0.95

1901

21188

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.21

2.36

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1058

0.71

2.36

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

206

1.70

2.32

8.2

7.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

268

1.61

2.30

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

119

902

1.32

2.29

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

119

1.93

2.29

2.5

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

261

1.61

2.28

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

309

1.55

2.25

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1035

0.71

2.24

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

247

1.62

2.23

1.7

1.5

0.4

ug/l

0.01

140

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.10

2.22

8.6

8.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

135

1047

1.29

2.22

1.1

—

17.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1349

14531

0.92

2.21

4.6

32.5

32.7

0.26

945

9679

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

103

1365

0.75

2.20

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

121

1.90

2.20

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

1031

0.72

2.19

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1271

0.75

2.18

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1270

0.75

2.17

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.07

2.16

1.2

1.1

9.9

9.2

u/l

0.07

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1269

0.75

2.16

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

552

1.40

2.14

1.0

1.1

5.2

10.4

iu/ml

2.74

130

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1266

0.75

2.13

1.4

—

(40768793) Breast Pathology biopsy report

145

1828

0.79

2.12

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

306

1.54

2.12

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.36

2.11

1.8

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

206

1690

1.22

2.11

1.7

1.4

158.5

198.2

pmol/l

0.65

198

1635

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

168

1.73

2.06

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

206

1.65

2.06

1.6

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

176

1.71

2.04

1.5

1.2

60.9

600.3

ng/l

0.64

120

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.17

2.04

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

162

1.73

2.01

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

739

1.33

2.00

2.4

1.9

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

239

1.59

2.00

1.3

1.2

107.4

58.5

mg/l

0.18

179

(3025018) Bordetella pertussis Ab [Titer] in Serum

493

1.40

1.98

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.14

1.97

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

156

1.73

1.95

1.4

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

289

2468

1.17

1.94

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.44

1.92

3.2

3.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

172

1.69

1.92

1.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

599

1.35

1.90

1.4

6.9

6.2

u/l

0.13

504

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

373

1.45

1.87

1.3

3.4

4.2

umol/l

1.20

344

(43055514) Macroprolactin [Presence] in Serum or Plasma

175

1.66

1.81

2.0

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

104

804

1.30

1.81

1.3

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

107

831

1.29

1.80

1.2

34.7

76.8

u/ml

—

(3017509) Phencyclidine [Presence] in Urine

2.06

1.80

3.2

1.6

—

(3007733) Chloride [Moles/volume] in Urine

2.76

1.79

2.5

1.1

89.5

73.4

mmol/l

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

107

835

1.28

1.75

1.2

17.0

33.6

u/ml

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.85

1.71

1.6

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

364

1.43

1.71

4.4

5.3

67.2

70.3

0.27

290

(3025130) Human papilloma virus identified in Specimen

104

813

1.28

1.69

1.8

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

119

1.77

1.65

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.89

1.64

1.1

1.2

0.1

0.6

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

732

6711

1.10

1.62

1.7

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

3.57

1.61

1.0

1.1

2120.0

1881.4

titre

—

(3045424) Erythrocytes [Presence] in Urine

223

1899

1.18

1.61

1.4

1.5

—

(4027681)

522

1.34

1.61

1.2

—

(3051339) Copper [Moles/volume] in Blood

2.14

1.60

1.1

1.2

15.1

16.1

umol/l

0.26

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

357

3151

1.14

1.59

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

159

1.64

1.58

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

404

1.39

1.58

1.2

1.1

—

(3016135) IgD [Mass/volume] in Serum

3.00

1.58

1.0

1.2

32.7

136.0

mg/l

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.69

1.58

6.1

6.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

672

1.30

1.57

1.1

275.6

293.0

mg/l

0.31

589

(44806420)

413

1.38

1.57

2.2

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

646

1.30

1.57

1.1

—

(3001729) Color of Synovial fluid

114

1.75

1.55

1.7

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

613

0.70

1.55

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10998

111197

0.96

1.54

5.4

5.1

2.4

2.6

mmol/l

86.40

10013

100970

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.03

1.53

1.1

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.33

1.52

1.2

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10968

108402

1.04

1.51

5.4

4.8

6.2

6.0

mmol/l

30.21

9867

97238

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

162

1.61

1.48

2.0

2.2

—

(3000285) Sodium [Moles/volume] in Blood

178

1.57

1.48

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

707

1.27

1.45

1.2

1.1

44.4

43.8

mg/l

0.03

590

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

117

1.71

1.44

1.2

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

102

1.77

1.44

3.9

2.6

223.7

444.1

umol/l

0.67

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

390

0.64

1.44

1.1

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1573

0.82

1.41

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

221

1.49

1.40

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

137

0.44

1.39

1.3

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

415

1.35

1.38

1.1

220.5

398.1

ng/l

0.74

102

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.83

1.35

1.9

5.3

—

(3013762) Body weight Measured

0.00

1.34

0.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

232

1.47

1.33

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

610

1.28

1.33

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

799

1.24

1.30

1.2

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

121

1.65

1.30

1.1

1.0

—

(36303858) Crystals [Presence] in Urine

2.78

1.28

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

361

1.36

1.27

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

130

1.62

1.26

1.8

1.7

—

(4034850)

414

3750

1.11

1.24

17.0

11.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

123

1.63

1.23

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.00

1.23

3.7

3.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

1.60

1.23

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

264

2335

1.13

1.21

1.9

185.8

198.0

pmol/l

1.16

245

2178

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

124

1.61

1.20

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.31

1.18

1.0

1.1

1.3

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

218

2485

0.88

1.18

1.5

—

(1002224) Polysomnography panel

326

3626

0.90

1.18

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

174

1.49

1.14

2.0

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

360

1.33

1.14

1.1

—

(3025577) Chromium [Mass/volume] in Blood

103

851

1.21

1.12

2.1

2.0

2.4

2.3

ug/l

0.13

697

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

175

1.49

1.12

1.5

1.2

21.9

20.3

mmol/l

0.72

144

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

563

0.75

1.12

1.3

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.00

1.12

1.0

1.1

—

21.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

459

1.29

1.09

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

145

1.52

1.05

1.2

6.1

8.3

mg/l

0.97

134

(3020874) Milk IgE Ab [Units/volume] in Serum

471

1.27

1.05

1.1

0.6

3.4

u/ml

2.32

166

(3028679) Herpes simplex virus Ab [Presence] in Serum

480

1.27

1.04

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10656

107519

0.97

1.03

4.8

4.5

1.4

mmol/l

40.14

9682

97469

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.27

1.03

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.06

1.02

1.6

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.83

1.02

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

130

1.54

1.02

1.5

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

104

871

1.20

1.01

1.9

4.2

3.6

ug/l

0.23

758

(3006462) Nitrate [Presence] in Urine

586

0.77

1.00

4.4

3.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

109

0.46

1.00

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

172

1.45

0.99

1.8

2.8

0.5

0.4

u/field

0.16

172

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

123

1.55

0.99

1.1

6.5

15.7

iu/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10758

108502

0.97

0.99

4.9

4.5

4.3

4.5

mmol/l

87.00

9869

99027

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.80

0.98

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

206

1.41

0.98

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.94

0.97

1.0

—

(40763590) HLA-DQ beta [Type]

1.94

0.97

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.77

0.94

1.4

1.3

275.6

317.0

umol/24h

0.33

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

200

1.40

0.93

2.7

2.8

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.82

0.92

1.0

1.1

182.2

212.3

pmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

262

1.34

0.89

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

519

1.23

0.89

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

228

1.36

0.88

1.1

0.6

0.7

umol/24h

—

108

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

368

1.28

0.87

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

220

1.36

0.87

1.2

1.3

—

(4211845)

638

0.80

0.86

4.4

3.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.72

0.86

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

231

1.34

0.82

1.3

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.69

0.82

1.4

1.6

2.3

1.1

mg/l

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.69

0.82

7.8

10.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

800

1.18

0.81

3.8

4.9

360.6

94.3

u/ml

0.77

238

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.64

0.81

1.1

—

(3003129) Base excess in Capillary blood by calculation

355

1.27

0.80

1.6

1.8

0.3

0.5

mmol/l

0.11

328

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

108

1246

0.87

0.78

1.2

7.8

7.6

mmol/l

0.36

883

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

140

1.43

0.76

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.76

0.76

1.3

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.64

0.75

2.3

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

906

0.85

0.73

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.61

0.72

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.92

0.70

1.0

1.8

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.55

0.69

1.1

1.7

0.7

12.3

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1019

9781

1.04

0.68

2.2

2.1

11.8

12.2

nmol/l

0.57

857

8556

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

319

1.25

0.68

1.4

1.3

40.1

34.4

0.31

206

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1123

10808

1.04

0.67

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.54

0.65

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

405

0.79

0.64

1.9

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

313

1.25

0.64

1.3

1.2

161.2

136.6

nmol/l

0.22

231

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.63

0.62

1.1

1622.9

368.1

u/l

—

(3046861) Legionella sp Ag [Presence] in Urine

1.55

0.62

1.0

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.59

0.61

1.4

1.6

1.5

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.59

0.61

1.4

1.6

0.7

0.9

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.59

0.61

1.4

1.6

1.5

1.4

mg/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

200

1.30

0.60

1.7

1.9

2.1

ug/l

0.24

103

(3012494) Peanut IgE Ab [Units/volume] in Serum

254

1.26

0.59

1.1

0.4

19.2

u/ml

0.78

140

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

547

1.17

0.58

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.51

0.58

1.0

1.1

271.6

240.1

nmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

166

1.33

0.58

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

321

0.78

0.58

1.5

1.9

—

(40760409) HLA-A [Type] by High resolution

1.67

0.56

1.0

—

(40760410) HLA-B [Type] by High resolution

1.67

0.56

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.67

0.56

1.0

1.1

—

(3013862) HLA-DP [Type]

1.62

0.55

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.62

0.55

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

150

1.33

0.55

2.1

2.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.58

0.54

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

269

1.23

0.50

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

269

1.23

0.50

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

269

1.23

0.50

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

269

1.23

0.50

1.2

1.1

—

(4015189)

370

1.19

0.50

2.0

2.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

190

0.74

0.49

3.2

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

189

0.74

0.48

6.4

5.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.45

0.48

2.5

2.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.49

0.47

1.0

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

343

3244

1.06

0.47

1.7

43.0

42.7

nmol/l

0.06

327

3127

(40765089) Chromosome analysis panel - Blood by G-banded

222

0.77

0.47

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

888

0.89

0.46

1.4

1.3

69.2

97.6

pmol/l

0.38

286

(4024509)

103

1140

0.90

0.46

1.8

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

1263

0.91

0.45

1.1

6.6

2.1

u/ml

0.48

315

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.40

0.44

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.40

0.44

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

394

0.84

0.43

1.4

1.5

8.1

mmol/l

0.00

227

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

871

0.89

0.42

1.1

1.3

0.3

u/ml

0.82

223

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.43

0.42

1.3

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.47

0.40

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.36

0.40

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

142

1.27

0.38

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

151

1.26

0.38

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

252

1.19

0.37

4.6

6.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

149

1387

1.07

0.37

1.1

20.1

15.0

au/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

218

1.19

0.34

1.7

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.33

0.33

1.3

1.5

25.8

15.7

nmol/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1041

0.92

0.32

1.1

4.6

4.2

u/ml

0.09

424

(44813793)

645

1.10

0.32

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

257

1.17

0.31

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.30

0.30

10.1

8.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

138

1.23

0.30

1.3

1.2

5.5

6.3

mmol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.33

0.30

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.25

0.29

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

324

0.86

0.29

1.2

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

111

0.72

0.28

2.1

2.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.29

0.28

1.3

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.69

0.26

1.8

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.30

0.26

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.30

0.26

1.1

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.20

0.25

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.20

0.25

1.1

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.20

0.25

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

570

1.09

0.24

5.7

6.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

133

1.20

0.24

16.0

9.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

1.20

0.24

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.73

0.24

1.0

—

(40768795) Lymph node Pathology biopsy report

114

1074

1.06

0.24

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

1061

0.94

0.22

1.8

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

163

1.17

0.21

1.6

1.4

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

65.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

672

1.07

0.21

1.2

1.3

0.2

1.4

u/ml

3.06

314

(4146454)

148

1413

1.05

0.21

2.8

2.7

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

35.9

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.21

0.0

1.6

—

11.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

192

1845

1.04

0.20

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.25

0.20

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

115

0.78

0.20

4.3

5.0

—

(40762814) Titanium [Mass/volume] in Blood

232

1.12

0.18

2.4

2.2

3.4

3.6

ug/l

0.14

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2830

28515

0.99

0.18

1.7

1.6

1.4

1.3

mmol/l

5.77

2373

23667

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

786

1.06

0.17

1.0

252.0

329.2

ng/l

3.99

529

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

120

0.83

0.16

1.5

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

787

1.05

0.16

1.0

759.5

721.6

ng/l

0.32

512

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

661

1.06

0.16

1.3

1.4

3.3

4.3

ug/l

0.92

575

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.10

0.15

1.0

—

(3019174) dRVVT (LA screen)

1.12

0.15

1.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

790

1.05

0.15

1.0

31.1

44.2

ng/l

3.91

520

(3020650) Glucose [Presence] in Urine

265

1.09

0.14

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

227

1.10

0.14

2.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

429

0.93

0.14

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5163

51827

0.99

0.13

5.0

5.2

4.3

3.9

ug/l

0.19

4491

46064

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

109

0.83

0.13

1.2

1.1

1.8

1.7

umol/24h

—

109

(3024869) Neuronal Ab [Presence] in Serum

231

0.91

0.12

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

171

1.11

0.12

1.3

1.2

29.1

52.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

443

1.06

0.12

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

395

1.06

0.11

1.0

1.1

1.5

1.9

u/ml

—

(3006598) pH of Arterial cord blood

115

0.87

0.10

1.0

—

(4094501)

289

2941

0.98

0.10

1.1

—

(3022689) Creatine [Moles/volume] in Urine

341

0.94

0.10

1.2

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.11

0.09

1.4

1.3

1.5

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

117

1139

1.03

0.09

1.4

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

165

0.91

0.09

1.1

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.09

0.08

1.0

133.7

167.3

g/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.77

0.08

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.03

0.07

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10413

103983

1.00

0.07

4.4

4.0

1.4

1.3

mmol/l

15.28

9408

93462

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

176

1.08

0.07

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

402

1.04

0.07

1.1

5.0

5.8

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.83

0.07

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

722

7267

0.99

0.06

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1088

10933

0.99

0.06

1.7

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

970

0.98

0.05

1.1

7.2

4.1

u/ml

0.68

401

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

487

1.03

0.04

1.1

1.0

1.1

u/l

0.37

227

(3015183) Erythrocyte sedimentation rate

408

1.03

0.03

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

270

0.96

0.03

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

1365

0.99

0.03

1.1

1.3

1.0

u/ml

0.19

604

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

213

2146

0.99

0.03

1.5

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

466

0.99

0.00

1.1

1.5

7.2

u/ml

0.67

142

(3003888) Timothy IgE Ab [Units/volume] in Serum

140

1406

1.00

0.00

1.1

3.9

5.2

u/ml

0.45

726

(3005082) Progesterone [Moles/volume] in Serum or Plasma

251

1.00

0.00

1.3

1.4

21.4

33.2

nmol/l

1.31

221

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

158

1578

1.00

0.00

1.2

1.1

2.7

1.5

u/ml

0.52

668

(4133840)

267

1.01

0.00

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

0.96

0.00

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

531

1.00

0.00

4.5

5.4

1237.7

7274.9

u/ml

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.99

0.00

1.0

1.1

—

5.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.99

0.00

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.95

0.00

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3003577) Lead [Moles/volume] in Blood

0.96

0.00

1.1

1.2

—

0.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

0.8

3.3

u/ml

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.3

—

(3025966) Peach IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

3.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

39.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.91

0.00

1.5

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

1.4

2.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_GIBLEEDING – GI-bleeding

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

GI-bleeding

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for GI-bleeding (K11_GIBLEEDING)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints